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Abstract.
The hypothesis that p53 deficiency enhances survival of DNA-damage bearing cells
was investigated in embryonic stem (ES) cells with inactivation of one or both
endogenous p53 genes. ES cells were treated with a variety of DNA-damaging
agents including UV light, y-radiation and the topoisomerase I and II inhibitors,
camptothecin and etoposide. Both topoisomerase inhibitors rapidly induced high
levels of apoptosis in wild-type ES cells resulting in loss ofmost of the cell
population within 48 hours. Consistent with results previously obtained from other
cell types, the apoptotic response to etoposide was found to be p53-dependent at low
doses but at the highest dose used p53-independent pathways became evident.
Following UV-C irradiation, p53-protein was rapidly induced in wild-type cells and
p53-dependent apoptosis followed within 8 hours, leading to death of the majority of
cells within 36 hours. Treatment with ionising radiation led to enhanced expression
of p53 but resulted in little induction of apoptosis irrespective of p53 status.
Evasion of apoptosis in the short term does not necessarily imply a continued
capacity for growth and therefore long term survival, measured by clonogenic
potential, was also examined. Following both UV and y-irradiation, clonogenic
survival ofyoi-null cells was significantly higher than survival of wild-type cells,
particularly after high levels of DNA-damage where survival was enhanced more
than ten-fold.
It has been predicted that a yO"3-null environment will result in an increased mutation
rate due to loss of the normal apoptotic pathway and subsequent survival of cells
bearing DNA damage. This prompted an investigation of the mutation frequency at
the hprt locus after UV and y-irradiation. After UV-irradiation, the hprt mutation
frequency was found to be dependent upon UV dose and influenced by p53 status. In
contrast, the incidence of hprt mutation following y-irradiation did not differ
significantly between wild-type and pai-null survivors.
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In summary, the data confirm that p53 restricts the numbers of cells bearing
mutations that survive DNA damage induced by either agent, albeit by mechanisms
that differ. Thus, following ionising radiation there is a p53-dependent increase in
the number ofmutation bearing clones as a consequence of increased clonogenicity,
whereas following treatment with UV-C changes to both mutation frequency
amongst surviving cells and clonogenicity appear to be important.
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1.1 A pathway to death.
The process of apoptosis was first described as a cellular process characterised by
defined structural changes. Developments in the past five years have led to the
description of a biochemical pathway dependent on the activity of a set of genes
which are also familiar in cancer. One major feature of this pathway is the existence
of a terminal component that is common to a wide variety of stimuli, both
pathological and physiological. The question therefore arises of what happens when
genes involved in the apoptosis pathway are deficient? Do cells die by another route,
or do they survive, and if so are they normal or perhaps the precursors of cancer
cells? This thesis attempts to answer some of these questions. It studies apoptosis in
response to DNA (deoxyribonucleic acid) injury, in particular to two agents with
differing modes of action, and analyses the effect on apoptosis of a single genetic
change: the removal of p53. In addition, it attempts to identify conditions in which
the absence of p53 leads to increased survival, both in terms of escape from
immediate apoptosis and continued proliferation thereafter. Finally, it examines the
phenotype, with regard to the acquisition ofmutations, of those cells which without
the loss of p53 would otherwise have been deleted from the population.
As a background to these studies, it is necessary to describe the cell biology of
apoptosis - both the common terminal pathway and some of the regulatory genes, in
particular p53, concerned with coupling apoptosis to DNA damage.
1.2 Apoptosis.
It has long been recognised that cell death is an essential process in embryonic
development (Glucksmann, 1951; Saunders and Fallon, 1966) but the discovery that
this process, with its typical structural changes, also occurred in cells dying from a
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wide variety of causes led to the definition of the term apoptosis (Kerr et al., 1972).
The importance of the apoptotic process to the survival of both individual cells and
the organism as a whole has only been recognised relatively recently. It is now
known that it plays a role in a broad range of physiological processes, the failure of
which often results in disease.
1.2.1 The physiological role of apoptosis.
The earliest reports of cell death, now over a century old (Beard, 1896, in Milligan
and Schwartz, 1997), were from observations of embryonic development. It is now
clear that apoptosis plays an essential role in many, if not all, developmental
processes and its failure results in a wide variety of congenital abnormalities
(reviewed by Milligan and Schwartz, 1997). During the development of the foot, the
interdigital cells are removed by apoptosis and failure of this process results in excess
skin, or webbing, between the digits (Garcia-Martinez et al., 1993). Similarly,
apoptotic regression of the midline epithelium is required for formation of the palate
(Pratt and Greene, 1976; Mori et al., 1994). Even in adult life, apoptosis continues to
remove cells that are surplus to requirements. Examples include; the involution of
the mammary gland after lactation, regression of the adrenal cortex in response to
decreases in adrenocorticotrophic hormone and breakdown of the uterine
endometrium during the menstrual cycle (Wyllie et al., 1973; Hopwood and Levison,
1976; Walker et al., 1989; Strange et al., 1992).
Another crucial physiological function for apoptosis is in the immune system.
During development of the immune system, the vast majority of T and B
lymphocytes die by apoptosis. Here apoptosis occurs by default in the absence of
survival signals. In the case of B cells, survival signals are only produced by the
expression on the cell surface of an antigen receptor and successful signal
transduction, thus eliminating cells without functional antigen receptors (Tonegawa,
1983). A similar process occurs in T cells, with cells failing to make successful T
cell receptor gene rearrangements again being deleted by apoptosis (Raulet et al.,
1985). Negative selection of autoreactive T and B cells also occurs by apoptosis
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(Miller and Heath, 1993; Nemazee and Burki, 1989), as does the removal of
activated mature T and B cells once their purpose has been served (Russell. 1995).
Cytotoxic T lymphocytes and natural killer cells are specialised immune cells which
have the ability to destroy target cells. Target cells are recognised by interactions
between receptors on the surface of the killer cell and antigens on the surface of the
target. The killer cell is able to induce apoptosis in the target cell, either via cell-
surface determinant 95 (CD95) signalling or exocytosis of granules containing
perforin and granzymes (Rouvier et al., 1993; Darmon et al., 1995). Inability to
produce functional antigen receptors, for example due to loss of DNA-dependent
protein kinase activity (DNA-PK, Blunt et al., 1995), results in severe combined
immunodeficiency. In this case, disease is associated not with failure of the death
pathway but is a normal response to non-functional receptor gene rearrangements.
Immunological disorders can also result from abnormalities in apoptosis in lymphoid
cells, for example mutations in CD95 cause an autoimmune lymphoproliferative
disorder. Thus, the immune system is dependent upon a finely balanced equilibrium
between proliferation and apoptosis and any perturbations to the system have serious
repercussions for its effectiveness.
1.2.2 Apoptosis and cell injury.
Apoptosis is also a critical component of the cellular response to injury. Apoptosis
may be initiated in response to a broad range of types of cellular injury including
DNA damage, mitochondrial injury, cell membrane injury and viral infection. The
question arises of how cell injury initiates apoptosis and to what extent does the
cellular response to injury share a common pathway with the physiological induction
of apoptosis.
1.2.3 Structural changes during cell death.
The first evidence for a single common pathway to apoptosis was morphological.
During apoptosis cells undergo a well characterised series of physical changes. With
the onset of apoptosis, cells lose contact with neighbouring cells and a period of
intense membrane-blebbing ensues. This is followed by condensation of both the
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cytoplasm and nuclear chromatin. The nuclear chromatin becomes peripheralised,
forming dense cap-like structures along the inner margin of the nuclear envelope.
This is accompanied by redistribution of the nuclear pores and breakdown of the
nuclear lamina. Finally, the cell forms a cluster ofmembrane bound apoptotic bodies
which, within tissues and sometimes also in vitro, are subsequently phagocytosed by
either neighbouring cells or specialist phagocytes. Apoptosis in many, but not all,
cells is also characterised by fragmentation of genomic DNA by an endogenous
endonuclease. Genomic DNA is cleaved first into large fragments of between 50 and
300 kilo base-pairs (kb), described as domain cleavage, and subsequently within the
internucleosomal linker regions resulting in a DNA ladder of fragments differing in
size by around 180 base-pairs (bp). One of the most striking features of apoptosis is
the speed with which cells are removed from tissues: the entire process is normally
completed within a few hours (Kerr, 1971; Wyllie, 1980; Allen, 1987; Kerr et al.,
1987; Lazebnik et al., 1993).
1.2.4 The genetic regulation of apoptosis.
In the previous section the structural changes which occur during the apoptotic
process have been discussed but how is this process initiated and what are the
effector molecules? Our understanding of the regulation of apoptosis in mammals
has been greatly aided by a series of painstaking experiments elucidating the genetic
control of apoptosis during the development of the nematode worm, Caenorhabditis
elegans (reviewed by Miura and Yuan 1996). During nematode development, 131
cells die by apoptosis resulting in a worm incorporating only 1090 cells, each of
which can be examined by light microscopy. Each cell destined to die does so at a
time precisely predetermined by a genetically defined programme. Disruption of this
genetic pathway by mutagenesis has resulted in the identification of 14 genes
involved in the death pathway. These include genes involved in the commitment of
the cell to the death pathway, execution of cell death, engulfment of the dead cell and
its degradation. Probably the most significant of these are the three Caenorhabditis
elegans death iced) genes ced-3 , ced-4 and ced-9. Both ced-3 and ced-4 are
necessary and sufficient to initiate apoptosis (Xue et al., 1996; Hugunin et al., 1996;
16
Yuan and Horvitz, 1992) whilst ced-9 inhibits the death pathway and is necessary for
cell survival (Hengartner et al., 1992). Attempts to find the mammalian homologues
of these genes led to the discovery of homology between ced-3 and interleukin-1 [3-
converting enzyme (ICE or caspase-1), and ced-9 and a gene involved in human B-
cell lymphomas (BCL2).
1.2.4.1 Caspases, the effector molecules of the apoptotic pathway.
The first member of the caspase family to be identified was ICE (now called caspase
1), an enzyme responsible for the processing of the pro-inflammatory cytokine, pro
interleukin-1P (Thornberry et al., 1992). The discovery that this gene was
homologous to ced-3 (Yuan et al., 1993), prompted an intensive search for other
mammalian homologues and resulted in the discovery of a whole family of related
genes. To date, ten human caspases have been identified (reviewed by Thornberry,
1997a).
Caspases exist as proenzymes requiring proteolytic cleavage to an active form. The
proenzyme is composed of two subunits, an N-terminal prodomain of variable length
and in some enzymes, a linker region between the two subunits. Proteolytic cleavage
of the enzyme is thought to occur at Aspartic acid residues and results in removal of
the prodomain and separation of the two subunits, with loss of the linker region
where present. There is evidence to suggest that the mature form of the enzyme is a
tetramer formed from two of the smaller subunits and two large subunits (Thornberry
et al., 1992; Wilson et al., 1994; Walker et al., 1994). Phylogenetic comparisons of
the gene family have suggested that the enzymes may be grouped into two, or
possibly three, subfamilies (reviewed by Thornberry, 1997a). All caspases have a
requirement for an aspartic acid residue at the PI position; the first aa N-terminal to
the cleavage site. Differences between family members include variations in the size
of the prodomain and subunits, and differences in substrate specificity. Differences
in substrate specificity and the prodomains probably account for the functional
differences between family members. Several caspase family members have been
found to encode a number of splice variants. Isoforms of some family members,
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which include full-length and truncated proteins, have opposing functions as inducers
and inhibitors of apoptosis, possibly via a dominant negative inhibition mechanism.
There are several lines of evidence indicating that at least some caspases are
mediators ofmammalian apoptosis. First, cleavage and consequent activation of
certain caspases correlates temporally with the appearance of the apoptotic phenotype
(Schlegel et al., 1996; Duan et al., 1996; Orth et al., 1996). Second, caspases appear
to be responsible for the proteolytic cleavage of a number of proteins known to be
cleaved during apoptosis and involved in cellular homeostasis, repair and the
maintenance of cell structure (reviewed by Thornberry, 1997a). Third, studies with
viral and synthetic caspase inhibitors indicate that these inhibitors can prevent cell
death in response to a variety of inducing agents, in a wide range of cell types (for
examples, see Gagliardini et al., 1994; Lazebnik et al., 1994; Nicholson et al., 1995;
Enari et al., 1995). Finally, studies of gene knockout mice indicate that caspase 3
(CPP32/yama/apopain) is essential for apoptosis during the development of the brain
and nervous system (Kuida et al., 1996).
Although it is clear that caspases do play a role in apoptosis, there is also
considerable evidence to suggest a high degree of redundancy among family
members. The strongest evidence comes from knockout mice. Although, as
previously mentioned, caspase 3 knockout mice show severe defects in apoptosis of
neural tissues, caspase 1 null mice show no defects in apoptosis and mice deficient in
caspase 2 show only limited resistance to apoptosis in B-cells and oocytes (Kuida et
al., 1995; Kuida et al., 1996; Bergeron et al., cited in Dost, 1998). Duplication
among some family members of substrate specificities and the co-expression of
multiple caspases in many tissues is also consistent with some redundancy.
Current evidence indicates that caspases play roles in both the regulation and
execution of apoptosis. In CD95 mediated apoptosis, caspase 8 has been implicated
in upstream signalling events whilst caspase 3 is involved in the effector phase of cell
death. Caspase 8 physically interacts with the CD95 receptor complex linker protein
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via dimerisation between the death domain located within its own prodomain and the
death domain of the linker (Boldin et al., 1996; Muzio et al., 1996). Although the
mechanism is not yet clear, it is thought that this interaction results in cleavage and
activation of caspase 8, which then cleaves and activates other caspases, resulting in
a caspase cascade. Death domains have also been found in the prodomains of
caspases 2 and 10, suggesting a similar function for these enzymes (Fernandes-
Alnermi et al., 1996). In support of the theory of a cascade of protease activity,
various members of the caspase family have been shown to have protease activity
against other family members and when overexpressed in bacteria are able to catalyse
their own activation. In addition, the caspase inhibitor CrmA has been shown to
prevent the activation of caspases 3 and 7 although CrmA does not directly interact
with caspase 7 (Zhou et al., 1997; Chinnaiyan et al., 1996). It has recently been
shown that the prodomain of caspase 1 is required for its dimerisation and
autoactivation (Van Criekinge et al., 1996) and it has been speculated that those
caspases with long prodomains may play a regulatory role in apoptosis in which they
activate those caspases with short prodomains that may be unable to autoactivate in
cells (Thornberry, 1997b). The question still remains as to how this cascade of
protease activity is initiated. In the less complex pathway of C. elegans, it has been
suggested that CED-4 fulfils this role.
1.2.4.2 ced 4 and its mammalian homologue, Apafl.
The C. elegans gene ced-4 is required for ced-3 function and apoptosis. ced-3 is a
cysteine protease with aspartic acid specificity (caspase, see section 1.2.4.3) that
exists as a proenzyme requiring activation by cleavage. It has been proposed that this
activation is the function ofCED-4. Recent studies have shown that CED-3 and
CED-4 are able to physically interact (Chinnaiyan et al., 1997b; Irmler et al., 1997),
probably via their N-terminal, caspase recruitment domains (CARD) (Hofmann et
al., 1997). CED-9 is also able to bind to CED-4 and prevents its activation of CED-3
(Chinnaiyan et al., 1997b; James et al., 1997; Spector et al., 1997; Wu et al., 1997).
Several mammalian caspase activating proteins involved in the transduction of
apoptotic signals from the TNF (tumour necrosis factor) receptor family have been
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identified. These include FADD (fas-associated protein with death domain) which
binds certain caspases via its death effector domain (DED) and RAIDD (receptor
associated independent death domain) which binds through a CARD domain
(Hofmann et al., 1997). However, these proteins share little homology with CED-4
and are poorly blocked by BCL2. The first true homologue of CED-4, APAF1
(apoptotic protease activating factor 1), was reported only very recently (Zou et al.,
1997). It has an N-terminal CARD domain and a 320 aa central region sharing 22%
identity and 48% similarity with CED-4. APAF1 is able to bind cytochrome c and in
its presence and the presence ofATP and APAF3 (an unknown 45 kDa protein)
activates the CED-3 homologue, caspase 3. Very little is yet known about APAF1
and its role in mammalian apoptosis but it is clear that at least part of that role is the
activation of caspases. As previously discussed, the product of the C. elegans gene
ced-9 is thought to bind to CED-4 and prevents its activation of CED-3. One
possible mechanism by which BCL2 might inhibit the APAF1 mediated activation of
caspase 3 would be by preventing cytochrome c release from the mitochondria. In
support of this theory, release of cytochrome c in response to apoptotic stimuli is
blocked in cells overexpressing BCL2 (Kluck et al., 1997; Yang et al., 1997).
1.2.4.3 The BCL2 gene family.
BCL2 was first identified by its involvement in B-cell lymphomas where its
expression is commonly altered by the t(14; 18) translocation (Tsujimoto et al.,
1985). This translocation places the BCL2 gene in close proximity to enhancer
elements of the immunoglobulin heavy chain locus, resulting in increased expression
of the BCL2 protein and enhanced cellular survival (Vaux et al., 1988). BCL2 is
only one of a large family of related genes sharing up to four (BH1 to BH4) highly
conserved regions of homology (reviewed by Hale et al., 1996; Kroemer et al., 1997;
Kroemer 1997 and Brown 1997). Functionally, the family can be divided into two
groups; death inducing and death inhibiting proteins. Death inhibiting proteins
include products of the genes BCL2, Bclxl, Bcl-w, Bragl, Bfll, Mcll and Al and
death inducing proteins include the products of Bclxs, Box, Bak, Bad, Bid, Bik and
Hrk. Family members differ structurally and also in their expression patterns.
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Gene knock-out studies have helped to clarify the role of some BCL2 family
members in both embryonic development and the adult mouse. 5c/2-null mice
survive to birth but die shortly after showing polycystic kidney disease and massive
cell death in the thymus and spleen (Veis et al., 1993; Nakayama et al., 1994;
Kamada et al., 1995). Bclx-null mice die during embryonic development (day 13),
apparently due to extensive apoptotic death in the nervous and haematopoeitic
systems (Motoyama et al., 1995). The least affected phenotype is that of Bax knock¬
out mice which survive to adulthood but show male sterility and thymocyte and B-
cell hyperplasia (Knudson et al., 1995). These results suggest substantial functional
redundancy among BCL2 family members but indicate that particular members are
essential to some cell types at specific times.
Many of the BCL2 family proteins bear a carboxyterminal transmembrane region and
are predominantly localised within the outer mitochondrial membrane (Monaghan et
al., 1992; Jacobson et al., 1993; Krajewski et al., 1993; Muchmore et al., 1996).
BCL2 shows a discontinuous distribution in the mitochondrion consistent with an
association with the mitochondrial megachannel or permeability transition (PT) pore
(Zoratti and Szabo, 1995; Kroemer et al., 1997). Deletion of the transmembrane
domain in BCL2 abrogates or diminishes its ability to inhibit apoptosis (Tanaka et
al., 1993; Hockenberry et al., 1993). This loss of function can be restored by
exchanging the transmembrane domain for an equivalent sequence from either yeast
Mas-p70 or cytochrome b5 (Zhu et al., 1996). Similar experiments in yeast have
shown that membrane targeting is also crucial for the apoptosis-promoting activity of
BAX (Zha et al., 1996a). Thus, some BCL2 related proteins appear to require
mitochondrial localisation to regulate apoptosis.
The BCL2 gene family is characterised by the ability to form homodimers and
heterodimers with other family members, although heterodimerisation is often
selective. Over-expression ofBCL2 protects cells from apoptosis induced by a
variety of, but not all, inducing agents in many cell types. In addition, it can
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substitute for CED-9 in suppressing cell death in C. elegans. Over-expression of the
death-inducer BAX on the other hand, induces apoptosis and can antagonise the
protective function of BCL2. BAX was isolated as a BCL2 binding partner in
immunoprecipitation studies (Oltvai et al., 1993) suggesting that the formation of
BCL2/BAX heterodimers may play a role in the control of apoptosis. In support of
this hypothesis, BCL2 mutations in key regions of BH1 and BH2 that compromise
binding with BAX result in loss of the ability of BCL2 to inhibit apoptosis (Yin et
al., 1994). However, although this theory is consistent with the data, it is possible
that the true mechanism is more complex as most studies to date have only examined
interactions between one or two BCL2 family members in any one experimental
system. It is now clear that other family members also play a role in the regulation of
apoptosis and it is not possible to determine the effects of loss of BCL2/BAX binding
on these proteins and other interacting proteins not related to the BCL2 family.
Indeed, several mutations that disrupt the binding ofBCLX-L to BAX have been
reported that only partially abrogate its death repressor activity (Cheng et al., 1996).
Experiments suggest that the BH3 domain of death agonists is required both for
binding to BCL2 and BCLX-L and to promote apoptosis (Zha et al., 1996b; Hunter
and Parslow, 1996). However, a number of experiments on BH3 mutants of the
death agonist BID indicate that these two functions are controlled separately (Wang
et al., 1996a). BID, like BIK but unlike BAX, contains only the BH3 domain and not
BH1 and BH2 and may represent a death domain ligand for the membrane-bound
receptor BAX (Boyd et al., 1995; Wang et al., 1996a). The BH4 domain is
conserved among the death antagonist members of the BCL2 family but is either
lacking or ill-conserved in all but one (BCLX-S) death agonists. Deletion of this
domain does not affect dimerisation but results in either loss of function or
conversion of death antagonists to death agonists (Hunter et al., 1996). Intriguingly,
BH4 is required for the binding of a number of death regulatory proteins not related
to the BCL2 gene family. These include BAD, RAF1, CED-4, and calcineurin
(Wang et al., 1996b; Chinnaiyan et al., 1997a; Shibasaki et al., 1997).
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A further level of complexity is added to the system when we consider the effects of
post-translational modification on activity ofBCL2 family members. Serine
phosphorylation of BCL2 family members is known to affect their activity. Deletion
of a proposed negative regulatory loop, between BH4 and BH3, in BCL2 enhances its
ability to inhibit apoptosis (Uhlmann et al., 1996). In its unphosphorvlated form,
BAD heterodimerises with both BCL2 and BCLX-L, thereby promoting apoptosis.
In the presence of the survival factor IL-3, BAD is phosphorylated at serine residues
and bound to the 14-3-3 protein, thus rendering it unavailable for binding to BCL2 or
BCLX-L. Withdrawal of IL-3 results in dephosphorylation ofBAD and apoptosis.
Thus, substitution of phosphorylation sites in BAD favours its death inducing activity
(Zha et al., 1996c). BCL2 can also phosphorylate BAD via the targeting of its
binding partner, RAF1, to the mitochondrial membrane (Wang et al., 1996b).
BAX overexpression has been associated with a wide variety of apoptosis-related
changes and a correspondingly large number of theories have been suggested for its
mechanism of action. Only recently has it become clear that one of the first and most
universal manifestations of the apoptotic process is disruption of mitochondrial
membrane function. These changes include dissipation of the mitochondrial
transmembrane potential and/or the release ofmitochondrial proteases and
cytochrome c (Kroemer et al., 1995; Zamzami et al., 1995; Liu et al., 1996; Susin et
al., 1996; Yang et al., 1997; Kroemer et al., 1997). It is thought that the collapse of
the mitochondrial transmembrane potential may be due to the opening of the
mitochondrial PT pores, the consequences ofwhich could account for all of the
metabolic changes associated with apoptosis (Kroemer et al., 1997; Kroemer, 1997).
This theory is supported by studies showing that inhibition of PT abrogates all
mitochondrial and post-mitochondrial modifications associated with apoptosis in
some model systems but it is still not clear whether PT is influenced directly or
indirectly by BCL2 family members (Zamzami et al., 1995; Kroemer et al., 1997).
Intriguingly, recent NMR (nuclear magnetic resonance) and X-ray studies on the
structure of BCLX-L have revealed that there are seven alpha helices, the alignment
of which is similar to the membrane insertion domain of a group of bacterial toxins
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and suggests that this protein might act as some kind of pore or membrane channel
(Munchmore et al., 1996).
BCL2 is not able to inhibit apoptosis induced by all stimuli. It can inhibit p53-
dependent death in response to DNA-damage and death of growth factor deprived
cells but does not affect apoptosis induced by the T-cell protease, granzyme B (Chiou
et al., 1994; Vaux et al., 1992). These and other data allow us to place the BCL2
gene on a point of the apoptosis pathway upstream of the effector proteases but
downstream ofmany of the signalling molecules.
In summary, it appears that members of the BCL2 family interact with each other to
form a complex network of homo and heterodimers resulting in a dynamic
equilibrium of life and death signals. The details of this network are still largely
unknown but it seems that localisation to the mitochondrial membrane of some
members of the BCL2 family is essential for their efficient action and that post-
translational modification of proteins may also play a role. The mechanism by which
BCL2 family proteins effect their regulation of apoptosis is also unclear but may,
either directly or indirectly, involve loss ofmitochondrial transmembrane potential.
Loss of transmembrane potential might be expected to cause the release of
cytochrome c from the mitochondrion, which could, in the presence of the CED-4
homologue, APAF1, and its cofactors (APAF3 and ATP), result in the activation of
caspase 3 or other members of the caspase family, thus initiating the caspase cascade
and resulting in the induction of the structural changes associated with apoptosis.
1.2.4.4 Transcriptional signals for the activation of apoptosis.
The gene reaper is required for efficient apoptosis in response to both cell injury and
physiological stimuli in Drosophila and in its absence sensitivity to these stimuli is
reduced by around a thousand fold (White et al., 1996). Reaper shows some
structural homology to the CD95 death domain and may link into the same terminal
effector cascade as CD95 (Golstein et al., 1995). However, no mammalian
homologue for reaper has been reported yet. The proto-oncogene c-myc is an
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immediate-early growth response gene required for cell cycle progression. However,
overexpression of c-myc in serum starved fibroblasts results in the initiation of
apoptosis (Evan et al., 1992). Both the mitogenic and apoptotic functions of c-myc
seem to require the same gene domains. In addition, there is evidence that serum
starved fibroblasts enter S-phase prior to apoptosis (Hermeking and Eick, 1994).
These findings have led to the hypothesis that c-myc induces a state of readiness in
these fibroblasts which may result in either cell division or cell death depending on
the availability of local growth factors (Harrington et al., 1994). The oncosuppressor
gene Rbl is also involved in the control of cell cycle progression and is essential for
exit from the cycle into Go. When subjected to DNA damage, fibroblasts would
normally leave the cell cycle and enter Go arrest but in the presence of either
adenovirus ElA protein or human papillomavirus (HPV) E7 protein, both ofwhich
inactivate RB1 and thus prevent cell cycle exit, these cells undergo apoptosis
(Debbas and White, 1993; Slebos et al., 1994). In its active, hyperphosphorylated
form, RB 1 binds to and inhibits the activity of the E2F family of transcription factors
which are believed to mediate entry into S phase. Overexpression of E2F-1 also
results in the induction of apoptosis in serum starved fibroblasts (Shan and Lee,
1994; Qin et al., 1994). p53 and IRF1 are both tumour suppressor genes that can
signal apoptosis under certain circumstances. The effects of these two genes appear
to be interdependent and both share the ability to initiate either cell cycle arrest or
apoptosis (see section 1.3.5; Canman et al., 1995; Tamura et al., 1995). What factors
determine which of these end-points is chosen is still unclear.
1.3 The cellular response to DNA damage.
A great variety ofDNA lesions are of importance to the cell as they may result in
mutations or have the potential to disrupt transcription or replication. It is therefore
not surprising that there are sophisticated molecular systems for recognition of such
lesions and for coupling them to repair pathways. Nucleotide excision repair (NER)
is one of the most important cellular repair pathways and is involved in the repair of a
wide variety of bulky DNA lesions including those induced by UVC-irradiation and a
broad range of chemicals. The primary lesions induced by UVC-irradiation include
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6-4 photoproducts and cyclobutane pyrimidine dimers (Setlow and Carrier, 1966;
Lippke et al., 1981). These lesions result in distortions of the DNA helix which are
recognised by the proteins XPA (xeroderma pigmentosum complementation group
A) and, in the case of 6-4 photoproducts, XPE (xeroderma pigmentosum
complementation group E, Chu and Chang, 1988; Chu and Chang, 1990; Robins et
al., 1991). The mismatch repair pathway is involved in the repair ofmis-paired bases
formed during DNA replication, recombination and as a result ofDNA damage.
Here lesions are recognised primarily by the MSH2 (MutS homologue 2) protein
which is also involved in recruitment of the repair complex (reviewed by Kolodner,
1996). p53 has also been shown to bind to insertion/deletion mismatches consisting
of one or several extra bases on one strand but has little affinity for the classical type
ofmismatch recognised by MSH2. Depurination ofDNA is probably the most
common type of spontaneous DNA lesion and also results from oxidative damage
generated by ionising radiation. These lesions are usually repaired by pathways
involving AP endonucleases like the human AP endonuclease 1 (HAP1) and redox
factor 1 (REF1) (reviewed by Boulikas, 1996). A number of nuclear proteins are
able to recognise DNA single and double-strand breaks. These include poly(ADP-
ribose) polymerase (PARP), the c-terminal domain of p53, DNA-PK and DNA
ligases. PARP is rapidly induced by both single and double strand breaks and, until
recently, was thought to be involved in DNA repair. However, the generation of
PARP knockout mice has indicated that this protein is not required for either NER or
base excision repair (Wang et al., 1995). Of particular relevance to this study, is the
repair ofDNA double-strand breaks which are thought to be the most biologically
significant of the lesions resulting from ionising radiation. Recognition and repair of
this type of lesion involves DNA-PK (reviewed by Jackson, 1996). DNA-PK is a
multi-protein complex consisting of a catalytic subunit (DNA-PKcs or XRCC7) and
a DNA binding component, KU (also called XRCC5). DNA-PKcs shares homology
with a subgroup of the phosphatidylinositol (PI) 3-kinase family. Another subgroup
member is the recently cloned ATM gene which is mutated in individuals suffering
from ataxia-telangiectasia (AT) (reviewed by Jackson, 1996). AT cells display
elevated levels of genomic instability and are hypersensitive to ionising radiation and
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other agents that induce double-strand breaks, suggesting the involvement ofATM in
DNA-damage recognition or repair. AT cells also show a delayed p53 response to
irradiation and have impaired function for both the Gj/S and Gi/M checkpoints.
Whether or not ATM plays a direct role in DNA repair is still unclear but there is
some evidence to suggest that ATM is in involved in the regulation of nuclear factor
kB (NFkB) activity. In addition, it is tempting to speculate on a linkage between
ATM and p53 and it has been suggested that p53 might act as a DNA damage
targeting subunit for ATM (Jackson, 1996).
Many of the molecules involved in DNA-damage recognition and repair also link
into apoptotic pathways. The precise nature of this link is not fully understood but
this thesis is concerned with one pathway in particular - the p53-dependent DNA
damage response. A wide variety ofDNA-damaging agents have been shown to
induce apoptosis in numerous cell types. In many experimental systems, the tumour
suppressor gene p53 has been shown to play a central role in this signalling pathway.
However, this is not the only function of p53. It also has a role in cell cycle
regulation and has been implicated in differentiation, DNA damage recognition and
DNA repair.
1.3.1 p53 protein structure and function.
The cloning and sequencing ofp53 cDNAs from a variety of species has enabled
detailed analyses of the structure and function of the p53 protein. There are five
regions of the protein (domains I to V) which are evolutionarily highly conserved
indicating a central role in p53 activity (Soussi et al., 1990). Functionally, the
protein can be divided into three regions; the amino-terminal domain, the central core
and the carboxy-terminal domain (Figure 1). The amino-terminal domain binds to
several viral and cellular proteins including the TBP (TATA box binding protein)
component of the transcription factor TFIID and mdm2 (Seto et al., 1992; Chen et
al., 1993a; Chen et al., 1993b). In addition, the amino-terminal domain acts as a
transcriptional activator (Farmer et al., 1992). The central core of the p53 protein is



















Figure 1: Structure of the human p53 protein. Hatched boxes represent evolutionarily
conserved regions. N indicates the amino terminus and C the carboxyl terminus. NLS
represents nuclear localisation signals and P phosphorylation sites.
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1991; El-Diery et al., 1992; Funk et al., 1992; Zauberman et al., 1993) and crystal
structure analyses have revealed that the four conserved domains (II to IV) of the
central core are intimately involved in this process (Cho et al., 1994). The carboxy-
terminal domain has multiple functions. First, p53 is known to non-specifically bind
both single and double stranded DNA and catalyses DNA and RNA renaturation and
DNA strand transfer (Bakalkin et al., 1994; Brain and Jenkins, 1994) via its c-
terminal domain (Oberosler et al., 1993; Bakalkin et al., 1994; Brain and Jenkins,
1994). Second, this domain has also been demonstrated to recognise one to three
nucleotide long insertion/deletion mismatches (Lee et al., 1995). Finally, p53 exists
primarily as a tetramer (McCormick et al., 1981; Friedman et al., 1993) and the
region of oligomerisation has been localised to the c-terminus.
There is an alternative splice variant ofmurine p53 (ASp53) in which the 26 carboxy
terminal amino acids are substituted for 17 new amino acids (Wolf et al., 1985). The
physiological role of this splice variant is not yet known but it differs from the full
length p53 protein (NSp53) in a number ofways. ASp53 does not possess nucleic
acid reannealing activity and does not bind DNA non-specifically (Bayle et al., 1995;
Wu et al., 1995). Unlike NSp53, ASp53 displays constitutive sequence specific
binding activity and is not allosterically regulated by its c-terminus (Wu et al., 1994;
Bayle et al., 1995; see section 1.3.2). ASp53 is able to oligomerise with p53 and the
resulting complex shows the sequence specific binding properties of NSp53 (Wu et
al., 1994). Lastly, ASp53 and NSp53 may be expressed at different stages of the cell
cycle (Kulesz-Martin et al., 1994).
1.3.2 Activation of p53 following DNA damage.
Evidence for increases in p53 protein levels following DNA damage is abundant but
it is now becoming clear that this is probably not the only mechanism by which p53
is activated. In most cell types, wild-type p53 is present in very small quantities and
is turned over at an extremely rapid rate such that it has a half life measured in
minutes. After treatment with DNA-damaging agents, levels of p53 rise rapidly via a
process that is generally accepted to be post-transcriptional. This rise in p53 levels is
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thought to be due to stabilisation of the protein which is normally degraded by the
ubiquitin pathway (Kastan et al., 1991; Chowdary et al., 1994). In addition, p53
levels may also be partially controlled at the level of translation as it has been
suggested that p53 can inhibit translation of its own mRNA (Mosner et al., 1995).
The presence of strand breaks is known to be critical for the induction of p53 (Nelson
and Kastan, 1994) and even a single double-strand break may be sufficient to induce
p53 stabilisation (DiLeonardo et al., 1994). p53 exists in conformations that are both
active and inactive for sequence specific DNA binding activity and the c-terminus
has been shown to allosterically regulate this process. This regulatory function of the
c-terminus appears to be confined to the last 30 amino acids which, when deleted or
bound by antibody, stimulate binding activity (Hupp et al., 1992; Halazonetis et al.,
1993; Takenaka et al., 1995; Hupp et al., 1995). In addition, short (up to 30
nucleotides) sections of single-stranded DNA, through interaction with the c-
terminus, can stimulate sequence specific DNA binding of p53 (Jayaraman and
Prives, 1995). Phosphorylation may also be involved in the induction of p53 activity.
p53 is known to be phosphorylated at sites in the amino and carboxy termini, both in
vivo and in vitro (reviewed by Meek, 1994). A number of different kinases have
been shown to be involved in this process (reviewed by Meek, 1994).
Hyperphosphorylation of p53 has been found to increase steady-state levels of p53
(Zhang et al., 1994) and phosphorylation of the c-terminus has been shown to
increase DNA binding activity (Hupp et al., 1992; Takenaka et al., 1995; Hupp et al.,
1995). In addition, some mutation studies have demonstrated roles for
phosphorylation at particular sites in the function of p53 (Mayr et al., 1995) but there
is much conflicting evidence and others report little or no effect (Fuchs et al., 1995).
Despite these recent advances in our understanding of p53 phosphorylation, its
function is still largely unresolved.
Several proteins have recently been implicated in the regulation of p53-mediated
activation. These include WT1 (Wilms Tumour 1), pSS™01, REF1 and p300 which
are able to bind to p53 and enhance its transcriptional activation activity
(Maheswaran et al., 1995; Avantaggiati et al., 1997; Jayaraman et al., 1997;
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Garkavtsev et al., 1998). A number of these genes show considerable functional
homology with p53. For example, p33 not only enhances transcriptional activation
of p21 by p53, but is also able to block cell proliferation and induce apoptosis when
overexpressed (Garkavtsev et al., 1996; Helbing et al., 1997). Another candidate
tumour suppressor gene, IRF1, has been shown to suppress growth via the activation
of p21 and is also able to interact with p53 in a synergistic fashion in the activation of
this gene. In this case binding to p53 does not appear to be necessary, suggesting a
different mechanism to that described for p33 (Tanaka et al., 1996). Like p53, IRF1
is also able to induce apoptosis, independent of p53 activity, in response to DNA-
damage (Tamura et al., 1995). The recently discovered p53 homologue, p73, is able
to activate the transcription of p53-responsive genes and to induce apoptosis when
overexpressed (Jost et al., 1997). This gene shows considerable sequence homology
with p53, except in the carboxy terminal domain, but unlike p53, is expressed at low
levels in all normal tissues and is not induced in response to DNA damage suggesting
that it fulfils a different, and as yet unknown, purpose (Kaghad et al., 1997; Jost et
al., 1997). The relationship between all of these genes is still poorly understood but
they appear to constitute a group of genes with related, and perhaps overlapping,
functions.
The precise mechanism by which p53 activates transcription is not yet clear but, like
most well characterised activators, it appears to require interaction with the general
transcriptional machinery. TFIID is a transcription complex containing TBP and two
TBP-associated factors (TAFs), dTAFIMO and dTAFII60. p53 is known to interact
with TFIID and that interaction stimulates sequence specific binding of p53 to DNA
(Liu et al., 1993; Chen et al., 1993b). It is likely that it is p53's association with
dTAFIMO and dTAFII60, rather than TBP itself which is essential for transcriptional
activation (Lin et al., 1994; Thut et al., 1995; Lu and Levine, 1995).
1.3.3 p53-mediated transcriptional activation.
A large number of genes have been found to contain p53 binding sites and thus could
be targets for p53 transcriptional activation. Confirmation of the status ofmany of
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these candidate genes as true p53 targets is eagerly awaited but a number of good
candidates have already been identified. These include p21 (WAFl/Cipl), mdm2,
GADD45, cyclin G, Box and the insulin-like growth factor binding protein 3 (IGF-
BP3). The product of the p21 gene forms part of a quaternary complex which
includes cyclins, cyclin-dependent kinases (CDKs) and the proliferating cell nuclear
antigen (PCNA) (Xiong et al., 1993b). At high concentrations p21 inhibits the
function of CDKs, particularly those acting at the Gi phase of the cell cycle, and thus
is probably responsible, at least in part, for the p53-dependent Gi arrest observed
after DNA-damage (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993a).
Insulin-like growth factor binding protein 3 (IGFBP3) is induced following DNA-
damage and inhibits signalling via insulin-like growth factor. It is thus an anti-
mitogenic protein and suggests another route by which p53 might suppress growth
(Buckbinder et al., 1995). The mdm2 gene encodes a protein which binds to p53 and
results in repression of its transcriptional transactivation activity and enhanced
proteosome-dependent degradation (Momand et al., 1992; Oliner et al., 1993; Haupt
et al., 1997; Kubbutat et al., 1997). The mdm2 gene is itself a target of p53
activation implying an autoregulatory feed-back loop between p53 and mdm2 (Barak
et al., 1993; Perry et al., 1993; Wu et al., 1993). The cyclin G gene is induced, in a
p53-dependent manner, subsequent to DNA-damage but its function is not yet clear
(Okamoto and Beach, 1994; Zauberman et al., 1995). The product of the Bax gene
(see section 1.2.4.1) is an inducer of apoptosis which is activated, by p53, following
DNA-damage and provides a possible mechanism for p53-mediated apoptosis (Zhan
et al., 1994; Miyashita and Reed, 1995).
1.3.4 p53-mediated transcriptional repression.
The mechanism of p53-mediated transcriptional repression is not well understood.
p53 has been reported to repress the transcription of proteins driven by a broad range
of promoter structures and this repression activity has been proposed to play a role in
p53-mediated apoptosis. Both the amino- and carboxy-terminals have been
implicated in repression activity (Shiio et al., 1992; Sang et al., 1994; Subler et al.,
1994; Shaulian et al., 1995). It has been reported that only those promoters
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containing TATA boxes and not containing initiator elements are inhibited by p53
(Mack et al., 1993). Deletion studies indicate that binding to both TBP and TAFs
may be required for transcriptional repression (Sabbatini et al., 1995; Ko and Prives,
1996). It has been suggested that p53-mediated transcriptional repression may be the
result of the interaction and functional sequestration of components of the
transcriptional apparatus by p53 (Ko and Prives, 1996).
1.3.5 p53, cell cycle arrest and apoptosis.
Following exposure to DNA-damaging agents, levels of p53 rise rapidly and cells
may either enter apoptosis or undergo a Gi arrest (Fritsche et al. 1993). Both of these
processes have been shown to be p53-dependent in a variety of cell types (Kastan et
al., 1991; Kuerbitz et al., 1992; Yonish-Rouach et al., 1991; Clarke et al., 1993;
Lowe et al., 1993; Clarke et al., 1994; Morgenbesser et al., 1994; Lu and Lane, 1993;
Mortensen et al., 1992).
The p21 gene plays a critical role in p53-mediated Gi arrest. Subsequent to
irradiation, up-regulation of p21 can inhibit both cyclin E/CDK2 and cyclin
A/CDK2, resulting in the accumulation of hypophosphorylated RB and Gi arrest
(Dulic et al., 1994; Demers et al., 1994; Slebos et al., 1994). Studies showing that
p21 overexpression can lead to Gi arrest and that p21-null cells show defects in
radiation induced cell cycle arrest further support the crucial role of p21 in p53-
dependent Gj arrest, but the potential involvement of other p53 targets, perhaps p53-
binding protein 2 (53BP2, Naumovski and Cleary, 1996), cannot be excluded (Harper
et al., 1995; Brugarolas et al., 1995; Deng et al., 1995). In addition, recent evidence
has shown that p53-independent pathways to p21-mediated Gi arrest, involving the
transcription factor IRF1, also exist (Tanaka et al., 1996). Originally it was believed
that the role of p53-mediated Gi arrest was to allow time for DNA-repair before
continuation of the cell cycle (Kastan et al., 1991) however, it is now clear that Gi
arrest is not always a transitory response; following DNA-damage, human fibroblasts
enter a prolonged and irreversible Gi arrest (DiLeonardo et al., 1994). p53 has also
been implicated in G2 arrest (Ryan et al., 1993; Kulesz-Martin et al., 1994; Agarwal
et al., 1995; Aloni-Grinstein et al., 1995; Guillouf et al., 1995; Powell et al., 1995;
Stewert et al., 1995) and recent evidence has shown p53 to be involved in a mitotic
spindle checkpoint. When exposed to spindle inhibitors, /?5J-null murine fibroblasts,
unlike their wild-type counterparts, do not arrest but undergo multiple rounds of
DNA synthesis, without the appropriate chromosome segregation, resulting in the
formation of tetraploid and octaploid cells (Cross et al., 1995).
p53 has been shown to mediate apoptosis both when over-expressed in cell lines
lacking endogenous, wild-type p53 (Yonish-Rouach et al., 1991) and under
physiologically relevant conditions (Clarke et al., 1993; Lowe et al., 1993; Clarke et
al., 1994; Merrit et al., 1994). p53-dependent apoptosis has been observed in a wide
variety of cell types (reviewed by Oren, 1994) and in response to a broad range of
stimuli which include DNA-damaging agents, hypoxia, heat shock, survival or
growth factor withdrawal and some cytokines (Graeber et al., 1994; Canman et al.,
1995; Eizenberg et al., 1995). However, not all pathways to apoptosis are p53-
dependent; for example dexamethasone treatment of thymocytes results in p53-
independent apoptosis (Clarke et al., 1993). The p53-dependent apoptotic response
shows a gene-dose effect, with cells having only one functional copy of p53
exhibiting intermediate levels of apoptosis between that shown by wild-type and p53-
null cells (Clarke et al., 1993; Lowe et al., 1993). However, there is some evidence
to suggest that, at least in some cell types, the absence of p53 does not result in
reduced sensitivity to apoptosis but merely changes the kinetics of its induction (Xia
et al., 1995). The mechanism of p53 induced apoptosis is still poorly understood and
its resolution has been complicated by the fact that the majority of studies have used
cell types either over-expressing p53 or with genetic backgrounds in which the
normal function of p53 may be disrupted. Expression of the survival factor, BCL2,
can inhibit p53-mediated apoptosis (Debbas and White, 1993; Chiou et al., 1994; see
section 1.2.4.1) as can a variety of growth factors (Johnson et al., 1993; Yonish-
Rouach et al., 1993; Gottlieb et al., 1994; Canman et al., 1995). Although the ability
of p53 to function as a transcriptional activator is necessary for its mediation ofGi
arrest, several studies have indicated that this function may not be required, in some
cell types, for the induction of apoptosis (Caelles et al., 1994; Wagner at al., 1994;
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Haupt et al., 1996). It seems probable that there are at least two distinct mechanisms
via which p53 can mediate apoptosis, the first requiring transcriptional activation,
perhaps ofBAX (see sections 1.2.4.1 and 1.3.2), and the second not. Aside from its
function as a transcriptional repressor or activator, p53 also interacts directly with a
number of cellular proteins and it may be these interactions which are relevant to its
role in apoptosis. There is evidence that binding of the TFIIH protein complex is
critical for at least one pathway of p53-dependent apoptosis that does not require
p53-mediated transcriptional activation (Wang et al., 1996c).
When exposed to DNA-damaging agents, cells may respond in one of two ways; cell
cycle arrest or apoptosis. What determines which of these two processes is the
outcome of increased levels of p53 expression is still unclear but cell type appears to
be an important determining factor (Midgley et al., 1995; Haupt et al., 1996). There
is some data to suggest that, at least in some circumstances, p53 simultaneously
signals growth arrest and apoptosis and that, without downstream inhibition,
apoptosis is the normal outcome. For example, abrogation of p53-mediated
apoptosis, by BCL2, in a myeloid leukaemia cell line revealed a p53-dependent Gi
arrest (Guillouf et al., 1995). There is also substantial evidence indicating that
conflicting signals for proliferation and growth arrest result in the induction of
apoptosis. Thus, over-expression of c-myc in growth arrested murine fibroblasts
results in apoptosis but in the absence of p53 merely results in cell cycle re-entry
(Evan et al., 1992; Hermeking and Eick, 1994). Similar links between deregulation
of proliferation signals and apoptosis have been demonstrated in vivo (Morgenbesser
etal., 1994).
1.3.6 p53 and karyotypic instability.
It has been suggested that loss ofp53 results in karyotypic instability and evidence
supporting this hypothesis comes from a number of sources. Firstly, fibroblasts
derived from Li-Fraumeni patients (a familial cancer syndrome in which patients
develop a wide spectrum of primary tumours at an early age as a result of a germline
mutation in one allele of the p53 gene) and grown in vitro commonly develop
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chromosomal abnormalities (Bischoff et al., 1990). Similarly, the majority (67%) of
murine embryo fibroblasts derived from p53 -/- mice have been found to be
aneuploid by passage three and this proportion rises to 95% by passage 25 (Harvey et
al., 1993; Tsukada et al., 1993). Moreover, loss ofp53 is often associated with
aneuploidy (Meling et al., 1993; Purdie et al., 1994) and gene amplification (Yin et
al., 1992; Livingstone et al. 1992; Donehower et al., 1995) in a variety of tumour
types. Secondly, in vivo studies on a variety of cell types from /?53-null mice show an
elevated frequency of chromosomal abnormalities, frequent gene amplification and
abnormal centrosome amplification (Bouffler et al., 1995; Fukasawa et al., 1997).
Recent evidence has shown p53 to be involved in a mitotic spindle checkpoint and
when exposed to spindle inhibitors, loss of this checkpoint in /Oi-null cells results in
the accumulation of tetraploid and octaploid cells. It may be that loss of this
checkpoint is the causative factor in the observed in vivo increases in aneuploidy of
/?55-null cells (Cross et al., 1995; see section 1.3.5). However, the majority ofp53-
null mice survive to birth (Donehower et al., 1992), although they are subject to an
increased frequency of developmental abnormalities (Sah et al., 1995; Armstrong et
al., 1995), suggesting that there are other p53-independent mechanisms for the
maintenance of karyotypic stability.
1.3.7 The role of p53 in DNA repair.
Several authors have suggested that p53 may be required for NER but evidence for
this is conflicting. Both p21 and GADD45, which are induced by p53 following
DNA damage, bind to PCNA which is required for NER and DNA synthesis (Shivji
et al. 1992; Prelich et al. 1987). Binding of p21 to PCNA inhibits DNA replication
but not NER (Waga et al., 1994; Li et al., 1994) whilst the function of
GADD45/PCNA binding is still unclear (Smith et al., 1994; Kazantsev et al., 1995).
In addition, p53 has been shown to bind to a number of proteins known to be
involved in DNA repair and replication. These include replication protein A (RPA),
several components of the TFIIH transcription-repair factor (p62 and the helicases
XPD (xeroderma pigmentosum complementation group D, also known as
ERCC2/Rad3) and XPB (xeroderma pigmentosum complementation group B, also
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known as ERCC3) and CSB (Cockaynes syndrome complementation group B, also
known as ERCC6) (Dutta et al., 1993; He et al., 1993; Li and Botchan 1993; Wang
etal., 1994; Xiao et al., 1994; Wang et al., 1995; Leveillard et al., 1996). p53 is also
known to non-specifically bind both single and double stranded DNA and catalyses
DNA renaturation and strand transfer suggesting it may play a more direct role in
DNA repair (Bakalkin et al., 1994; Brain and Jenkins. 1994). Interactions ofRPA
and TFIIH with p53 are not, however, unique and may relate to the function of p53 as
a transcriptional transactivation protein (He et al., 1993; Li and Botchan, 1993; Xiao
et al., 1994; Tong et al., 1995). A role for p53 in DNA damage recognition has also
been suggested by the formation of stable complexes between the p53 protein and
insertion/deletion mismatches and irradiated DNA (Lee et al., 1995; Reed et al.,
1995). Disruption of normal p53 function in RKO cells has been shown to result in
reduced repair ofUVC induced damage (Smith et al., 1995) but perhaps the most
convincing evidence for the involvement of p53 in NER is the reduced repair
capacity of Li-Fraumeni syndrome cells which are heterozygous for p53 mutation
(Ford and Hanawalt, 1995; Wang et al., 1995). However, /oi-null mouse fibroblasts
display normal rates of repair (Ishizaki et al., 1994; Sands et al., 1995). Similarly,
p53-null and wild-type embryonic stem (ES) cells show a similar overall capacity to
repair lesions in a UVC damaged reporter plasmid although, unexpectedly, the rate of
repair was faster in/oi-null cells (Prost et al., 1998).
It has been predicted that a /?55-null environment would result in an increased
mutation frequency (Lane, 1992). In vivo studies in/?55-null mice transgenic for a
lacl (galactosidase inhibitor) lambda shuttle vector, termed Big Blue, suggest that
this is not the case as no increase in spontaneous mutation frequency was observed
(Nishino et al., 1995; Sands et al., 1995). However, the assay used in these studies is
only able to detect small mutations and not large deletions or insertions (Nishino et
al., 1995). The situation is less clear following high levels ofDNA damage. In vitro
studies on Big Blue embryonic fibroblasts treated with 4-nitroquinoline 1-oxide
(4NQO), which induces single strand breaks, again showed no greater increase in
mutation frequency in /o3-null cells (Sands et al., 1995) but an in vivo analysis of
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mutation frequency at the Dlb-l (Dolichos biflorus 1) locus in /Oi-null mice after J-
irradiation showed p53 dependence at high doses (6 Gy) (Clarke, et al., 1997).
1.3.8 p53 and differentiation.
It has been suggested that p53 plays a role in the regulation of differentiation of
several cell types based on observations correlating increased p53 expression with
the expression of cellular differentiation markers. Over-expression ofp53 in pre-B
cells results in a differentiated phenotype and the expression of immunoglobulin p.
heavy chain (Shaulsky et al., 1991). Similarly, introduction ofwild-type p53 in HL-
60 cells, K562 cells, squamous carcinoma cells or Friend virus transformed
erythroleukemic cells results in partial differentiation (Feinstein et al., 1992; Brenner
et al., 1993; Soddu et al., 1994; Bannerjee et al., 1995; Ehinger et al., 1995). In
addition, dominant negative mutants of p53 are able to suppress differentiation in
some untransformed cell types (Soddu et al., 1996). It is important to note that p53
also results in perturbation of cell cycle progression in these studies and thus it is
possible that the expression of differentiation markers is the result of proliferation
inhibition and not a direct consequence of p53 expression. Moreover, the
observation that differentiation of all of these cell types apparently proceeds normally
inp53-null mice indicates that p53 is not essential to this process.
1.4 Aims.
In summary, apoptosis is a controlled process of cell death that can be triggered by
both cellular injury and physiological stimuli. Whatever the triggering stimulus,
signalling pathways feed into a common terminal execution pathway. Cellular injury
stimuli include cell membrane injury, DNA damage and mitochondrial injury.
Physiological stimuli may induce apoptosis via either non-transcriptional pathways,
by binding of CD95 ligand for example, or by transcriptional activation of genes like
reaper and E2F1. It is also clear that these apoptosis signalling pathways are able to
interact with each other.
There is plentiful evidence that abnormalities in these pathways lead to disease.
Examples include autoimmune lymphoproliferative disorders caused by mutations in
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CD95; profound and lethal developmental disorders of the nervous system in caspase
3 deficient mice and developmental and immunological disorders ofmice deficient in
BCL2 and BCLX. Historically, cancer has been viewed as the result of abnormal
cellular proliferation but it is now widely recognised that this is an
oversimplification. Carcinogenesis is the result of failure of cellular homeostasis, a
finely tuned balance between both cellular proliferation and cell death. Cancer is a
multi-step process typically characterised by the accumulation of genetic lesions in
both of these processes and a number of tumour suppressors and oncogenes are now
known to be involved in the regulation of cell death (reviewed by Lyons and Clarke,
1997). As previously discussed, the BCL2 gene was first identified by its
involvement in B-cell lymphoma and p53 is also one of the most commonly mutated
genes in human cancers (Hollstein et al., 1994). In addition, a number of oncogenic
viruses, including HPV and Epstein-Barr virus (EBV), have developed strategies for
blocking apoptosis, emphasising the importance of this process in carcinogenesis
(reviewed by Young et al., 1997). This thesis aims to address some of the remaining
questions on the role of p53 in these processes. In particular, does the high frequency
of p53 mutation in cancer reflect the fact that absence of p53 function leads to
survival of cells with undetected or inappropriately repaired DNA-damage?
The aims of this study were to investigate the immediate and long term consequences
of a p55-null environment on cell survival and the acquisition of mutations
subsequent to treatment with DNA-damaging agents.
The majority of studies of this type have utilised either short-term primary cultures or
immortalised cell lines and thus data on stem cells, which are perhaps more relevant
to the development of neoplasia, are lacking. Because of the difficulties of working
on stem cells in vivo, it was decided that these relationships would be examined in
vitro using ES cells. ES cells are derived directly from the early embryo and are
capable of continuous, undifferentiated growth in vitro. ES cells are also pluripotent
and when introduced into an early embryo, participate fully in normal embryonic
development giving rise to chimaeric mice. It would be expected that damage to the
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DNA of ES cells would have far reaching repercussions for the organism as ES cells
ultimately contribute to all cell types. Consequently, it has been argued that
mechanisms for the resolution ofDNA damage, whether by repair or death, would be
particularly effective in these cells.
In order to achieve the aims of this project, it was necessary to obtain a yOi-null ES
cell line. This was derived from an existing cell line bearing a heterozygous, targeted
deletion of the p53 gene. Comparisons between wild-type, heterozygous and p53-
null cell lines were subsequently used to characterise the cellular response to DNA-
damage. Specifically, it was intended that the role of p53 in immediate and long
term survival and the acquisition ofmutations, subsequent to DNA-damage, should
be examined. To address these questions, several agents have been used to induce
DNA-damage in ES cells and the effects of a /?55-null environment on cell survival
have been assessed. As survival in the short term does not necessarily correlate with
continued proliferative capacity, both immediate survival, measured in terms of
apoptosis, and clonogenic survival have been investigated. In addition, the temporal
correlation between apoptosis and the expression of p53 has been examined. As
previously discussed, p53 has been implicated in DNA repair and it has been
predicted that its loss would result in an increased mutation frequency. In this
project, the role of p53 in the acquisition of mutations at the hypoxanthine
phosphoribosyl transferase (Hprt) locus has been assessed subsequent to two
different types ofDNA-damage; UVC-irradiation and y-irradiation. These two
DNA-damage inducing agents result in quite distinct spectrums ofDNA damage (see




Where not given in the text, suppliers of reagents are listed in appendix II. Deionised
distilled water (DDW) was prepared using the Elga Maxima system (Elga).
2.1 Cell Culture.
2.1.1 Cell lines.
All murine embryonic stem cell lines were derived from mouse strain 129/Ola. Wild-
type cell lines used included E14 (Hooper et al., 1987), CGR8 (Mountford et al.,
1994) and HM1, a spontaneous HPRTmutant derived from E14 (Magin et al., 1992).
The £>5J-null cell lines (R72D5, R72D27 and R72D54) were derived from the
heterozygous targeted cell line R72 (see section 2.1.6; Purdie, 1994; Clarke et al.,
1993). R72 was derived from the E14 wild-type ES cell line. R721, R722 and R723
are subclones ofR72.
2.1.2 Maintenance of stock ES cell cultures.
Cells were grown at 37°C and under 5% CO2 in CM5-5 cell culture medium (see
appendix I). The medium was replaced when a change in the colour of the medium
from red to amber indicated that it was becoming exhausted (usually daily). All
constituents of the medium and other tissue culture reagents were batch tested to
ensure that they were able to support ES cell growth. During batch testing, a single
new component was tested in medium otherwise derived from constituents that had
previously batch tested satisfactorily. A component was found to be acceptable if it
gave homogenous stem cell morphology, over a period of at least 10 days, to a
similar or greater level than previously tested medium and resulted in cloning
efficiencies between 10 and 30 % (see section 2.1.8 for clonogenic assay). In order
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to minimise all potential extraneous sources of variation and facilitate comparisons
between data points, medium and tissue culture reagents for use in any single
experiment were all derived from constituents from a single batch. Cells were sub-
cultured when sub-confluent and were routinely split 1 in 10 every three days
2.1.3 Production of recombinant LIF.
Cos-7 cells (Gluzman, 1981) were transfected with the murine leukaemic inhibitory
factor (LIF) expression vector pC10-6R (Smith et al., 1988). Cells were trypsinized
o
and resuspended in phosphate buffered saline (PBS) at a concentration of 1x10 /ml.
A 0.8ml aliquot of this cell suspension was electroporated with 120pg of LIF plasmid
at 200V and 500pFd. Cells were left for 10 minutes and then plated out in a 10cm
dish with 20ml ofmedium. The following day, the medium was removed and
replaced with 25ml of fresh medium. After three days, the conditioned medium was
collected and a further 25ml ofmedium added to the plates. This was removed after
two days, combined with the previous batch of conditioned medium and stored at -
70°C. The conditioned medium was tested for biological activity by monitoring the
morphology of ES cell cultures maintained in CM5-5 medium supplemented with
differing dilutions of the LIF medium. An excess of LIF did not appear to have any
adverse effects on either ES cell growth or differentiation state. Therefore, in
subsequent experiments LIF medium was used at double the lowest concentration
that gave homogenous stem cell morphology (usually around 1:1000).
2.1.4 Trypsinisation of cell cultures.
Prior to trypsinisation, fresh flasks were prepared by incubating for at least 15
minutes with 0.1% gelatin (see appendix I). Cultures were washed with PBS and
then incubated at 37°C with sufficient TVP (phosphate buffered trypsin/versine, see
appendix I) to cover the bottom surface of the flask. When cells had disaggregated
and could be dislodged from the bottom surface of the flask by gentle tapping, the
trypsin was neutralised by the addition of two volumes of fresh medium, and cells
transferred to fresh flasks. Cultures were left for at least two hours to allow cells to
adhere to the floor of the flask and then the medium was removed and replaced.
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2.1.5 Production of frozen cell stocks.
Large quantities of frozen cell stocks were prepared for each cell line used in order
that all experiments could be performed with cells of a similarly low passage. Sub-
confluent cells were trvpsinised as above and centrifuged at 100 x g for five minutes.
The growth medium was removed, and cells were resuspended at approximately 1 x
107/ml in CM5-5 medium supplemented with 10% foetal calf serum (FCS) and 10%
dimethyl sulphoxide (DMSO). One ml aliquots of cells were cooled to -70°C at
approximately l°C/min and then transferred to long term storage in liquid nitrogen
vapour. To thaw, cells were placed at 37°C, the suspension diluted with 5ml of
medium and centrifuged at 100 x g for five minutes. The supernatant was removed
and cells resuspended in 8ml of fresh medium, which was then used to inoculate a
25cm" flask. Cultures were left for at least two hours to allow cells to adhere to the
floor of the flask and then the medium was removed and replaced.
2.1.6 The derivation of/?5J-nulI ES cell lines by high G418 selection.
The antibiotic Geneticin (G418) is toxic to mammalian cells but resistance can be
conferred by the expression of the bacterial neomycin resistance gene (neo). The
high G418 selection technique is based on the principle that homozygous cells are
occasionally spontaneously produced from heterozygous cells in culture and that, if
heterozygotes bear a selectable marker closely linked to the gene of interest, such
homozygotes can be selected by the use of selective media at a concentration that is
normally toxic to heterozygote cells (Mortensen et al., 1992). The cell line R72 is
heterozygous for p53 and bears a neo resistance cassette in the targeted allele and was
thus thought to be suitable for this selection protocol.
R72 ES cells were plated on 10 10cm plates at 5xl06. The following day, medium
was removed and replaced with medium containing 0.25, 0.375, 0.5, 0.75 and 1
mg/ml active G418 (two plates at each dose). Cultures were maintained in this
selective medium for 10 days. Only those cultures maintained in 1mg/ml G418 gave
rise to clones, the remainder of the plates being confluent or sub-confluent. Clones
on the 1mg/ml plates were densely packed (around 1000 to 2000 colonies per plate)
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making it very difficult to isolate single clones and so a second series of plates were
set up, again using R72 ES cells, for selection in G418 concentrations of 1, 1.5 and
2mg/ml. Those plates selected in 2mg/ml G418 gave rise to fewer colonies (400 to
800 clones per plate) than those selected in lmg/ml but were still fairly densely
packed. Clones were isolated from both the 1 and 2 mg/ml selection regimes.
2.1.7 Isolation of clones.
The tips of glass Pasteur pipettes were heated in a Bunsen flame until the glass
became molten and then stretched. Careful control of the heating and stretching
process allowed the production of pipettes of varying bore width. Clones were
picked in a still air hood, under sterile conditions. Using a binocular dissecting
microscope (Wessex WZ1), individual clones were gently teased off the surface of
the plate with a very fine bore pipette. These clones were removed from the plate,
with as little medium as possible, using a wide bore pipette and placed in a second
sterile plate. Two drops of TVP were added to the clone and the plate placed at 37°C
for approximately five minutes to allow disaggregation of the clone. The clone was
passed through a fine Pasteur pipette (three to five cell widths wide) several times to
break apart the larger cell clumps and then placed in a single well of a 24 well plate
with 0.5 ml of medium. It was usually necessary to trypsinise clones and transfer
them to new wells at least once before a sub-confluent culture was obtained in order
to prevent excessive cell death and differentiation due to cell clumping. When sub-
confluent, clones were trypsinised, half of the cells frozen down and the remainder
pelleted and frozen at -20°C for DNA extraction and analysis. DNA analysis
revealed that some clones were not of monoclonal origin and thus clones of potential
interest were thawed, serially diluted (at concentrations ranging between 2 and 25
cells per well) and plated in 24 well plates. After careful observation of the plates to
confirm monoclonal origin, a second clone was selected and expanded for future
analysis.
2.1.8 Clonogenic survival Assays.
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Because of the anticipated reduction in clonogenic survival subsequent to DNA
damage, it is necessary to plate out treated cells at a higher cell density than would
normally be used to assess plating efficiency. It is known that the plating efficiency
ofmass cultures is much higher than that achieved in very sparse cultures and this
raises concerns over the suitability of such an assay when used to compare cells
seeded at a wide variety of cell densities. To address this issue it is necessary to
assess the linearity of the relationship between plating density and clonogenic
survival over as wide a range of plating densities as possible.
Cells were trypsinised, using standard protocols, and the trypsin neutralised with two
volumes of cell culture medium. An aliquot of cell suspension was removed and the
cell density counted using a haemocytometer. The suspension was also examined to
ensure it contained only single cells and not clumps. Cells were plated out, in
triplicate, at densities of 102, 2.5 x 102, 5 x 102, 7.5 x 102, 103, 2.5 x 103, 5 x 103, 7.5
x 103 and 104 cells per 10cm plate. Plates were maintained for 10 days and fed as
appropriate. After 10 days, the medium was removed from the plates and the cells
fixed in 70% bench alcohol (74°P). Plates were then stained in 5% Giemsa (Sigma),
and colonies counted. Morphology of the clones was assessed microscopically and
only those clones with predominantly ES cell morphology were counted (some
differentiation at the periphery of the colony was permitted). The results indicated
that over the plating density range of 102to 2.5 x 103, the relationship between
plating density and clonogenic survival was linear (Figure 2). At the higher plating
densities of 104, 7.5 x 10J and, to a lesser extent, 5.0 x 103 clones were very densely
packed (up to 1338 clones per 10cm plate) and thus the likelihood of an apparently
single clone actually being derived from two clones in close proximity was relatively
high. Consequently it is likely that cloning efficiency at these densities has been
underestimated and this would account for the slightly lower survival estimates
obtained. It was therefore decided that, provided the number of surviving clones lay
within the observed linear range, this assay could be used to assess the loss of
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Figure 2: Scatter plot showing the clonal survival of ES cells (El4) plated at
different densities to illustrate the relationship between plating density and survival.
46
After treatment with DNA-damaging agents, cells were trypsinised and counted using
a haemocytometer. Control plates were prepared with 10 cells per 10cm plate and a
range of cell densities from 103 to 106 prepared for treated cells. All plates were
prepared in triplicates or quadruplicates.
2.1.9 Hprt mutation assays.
Hypoxanthine phosphoribosyl transferase (HPRT) is a vital component of the salvage
pathways of purine synthesis and catalyses the regeneration of inosine
monophosphate (IMP) and guanine monophosphate (GMP) from hypoxanthine and
guanine respectively (Williamson et al., 1992). In its absence, cells are forced to use
the de novo purine synthesis pathways at a much greater energy cost. It is possible to
select both for and against Hprt mutants by the use of growth medium containing
either 6 amino-6-mercaptopurine (6-TG) or hypoxanthine, aminopterin and
thymidine (HAT) (Hooper, 1985). If 6-TG is included in the growth medium, cells
possessing active HPRT will metabolise this purine analogue, resulting in cell death.
Thus only Hprt mutants can survive 6-TG selection. Similarly, aminopterin blocks
the de novo synthesis pathway and thus HAT medium is toxic to cells not having an
active Hprt gene.
Before treatment with DNA-damaging agents, cultures were maintained in HAT
medium (see appendix I) for five days to remove any existing Hprt mutants from the
cultures. Cultures were then irradiated with either UVC or y-irradiation and
maintained in normal medium for seven days to allow for the depletion of any pre¬
existing HPRT in the cells. At no point were cell numbers allowed to fall below the
number originally irradiated. Cells were then plated out at a density of 5 x 105, on
10cm plates, with 6-TG medium (see appendix I). Twenty to 60 plates were used for
• 3each dose, depending on the expected mutation frequency. Control plates with 10
cells per plate (in quadruplicate) were also prepared and maintained on normal
growth medium. Plates were fixed and stained after ten days.
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2.2 The induction of DNA damage and subsequent analyses.
It was necessary to find a suitable DNA-damaging agent that could be used to
investigate the role of p53 in cell death and the acquisition ofmutations. Four DNA-
damaging agents were considered. These included UVC-radiation, y-radiation and the
topoisomerase I and II inhibitors, camptothecin and etoposide. The mechanism of
induction ofDNA damage differs for these agents and each results in a slightly
different spectrum of lesions. The most commonly formed lesions subsequent to
UVC-irradiation, are cyclobutane pyrimidine dimers and 6-4 photoproducts (Lippke
et al., 1981; Setlow and Carrier, 1966). These lesions are known to block DNA
synthesis and are repaired by the NER pathway, thus creating a transient single strand
break (ssb). y -irradiation causes a variety ofDNA lesions, predominantly ssbs and
base and sugar damage, but double strand breaks (dsb) appear to be the most
biologically significant lesion and it has been suggested that a single unrepaired dsb
is lethal (Frankenberg et al., 1981; Frankenberg-Schwager et al., 1982; Radford,
1985). Topoisomerase inhibitors bind to and stabilise the cleavable complex formed
by the binding of topoisomerases to DNA. This prevents re-ligation of the DNA
after cleavage and thus generates either double (etoposide) or single (camptothecin)
strand breaks (Long et al., 1984; Nelson et al., 1984; Hsiang et al., 1985). Elence, all
four stimuli induce strand breaks, although indirectly in the case ofUVC, and
consequently might be expected to induce the expression of p53.
2.2.1 UVC-irradiation.
UVC-irradiation was performed at 254 nm using a Spectrolinker XL-1500
(Spectronics Corp.). Cells were grown in monolayers, and all medium was removed
from plates prior to irradiation.
The shape of the first series of clonogenic survival curves obtained after UVC-
irradiation (Figure 3) was atypical. There was substantial but variable cell killing at
doses as low as 1 and 2 Jm"2, and at higher doses the curve flattened out with little
additional killing. This suggested possible methodological problems. Inaccuracies in
delivery of the UVC dose were found to be the cause. To address this problem, the
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Figure 3: Clonogenic survival ofwild-type (E14, solid symbols) and p53 null
(R72D5, open symbols) cells following UVC-irradiation. Results shown are from
two separate experiments and cells treated at the same time are depicted with the
same symbol type. Each data point represents the mean of four replicates.
UVC-irradiation cabinet was tested in collaboration with Dr S. Pye ( Medical
Physics, Western General Hospital. Edinburgh). A spectroradiometer (Macam
SRE100, 2nm bandwidth, double monochromater) and a filtered photodiode detector
(Macam UVC103 (254nm)) were used to achieve this. Three Spectrolinker XL-1500
(Spectronics Corp.) cabinets were tested, all of which were found to be inaccurate.
Two of the machines tested, including the one used in our experiments, were found
to have highly inaccurate internal sensors. The internal sensor's measurement of
irradience, used by the machine to calculate dose delivery times, varied by a factor of
up to five from the true irradience at the centre of the floor of the cabinet (Figure 4).
In addition, in all machines the irradience was not uniform across the floor of the
delivery chamber. The highest irradience was in the centre of the chamber (5.58
mWcm"2), and this fell to almost half (2.92 mWcnf2) at the edges. By using only the
central region (a square 20cm x 20cm) of the chamber it was possible to restrict this
variation to less than 15%. Finally, it was necessary to take into account the fact that
the sides of the plates in which cells were irradiated (which are practically UVC
opaque) would shadow cells at the edge of the plate, thus reducing the dose
delivered. A 5mm diameter sensor was used and the average dose over the outer
5mm was found to be 70% of that in the centre. Thus errors caused by this shadow
effect are likely to be small.
Although the Spectrolinker internal sensor was inaccurate, the timing mechanism
was found to perform correctly, and thus accurately measured doses could be
delivered. To ensure that the irradience was consistent from one dose to the next, the
machine was pre-warmed for two minutes prior to irradiation. However, because the
doses used were small, it was necessary to use an attenuator to achieve an
appropriate irradience. Suitable attenuators were made from multiple layers of thin,
semi-opaque plastic and were used in all subsequent experiments. These were
suspended 4cm above the cell cultures and extended to the walls of the cabinet so as
to prevent light leakage. The transmission, at 254nm, of the attenuators was
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Figure 4: Comparison of the irradience measurements obtained from the internal
sensor of the irradiation cabinet (open symbols) and spectroradiometer (closed
symbols).
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significantly. An attenuator consisting of two layers of plastic was found to have a
transmission of 5.6x10"J (+/- 5%) and a three layered attenuator 4.6x10"4 (+/- 5%).
Because of time constraints, it was not possible to repeat all of the experiments in
which UVC-irradiation had been used. A separate experiment was thus carried out in
which each of the irradiation protocols originally used was duplicated at least five
times, and the actual UVC dose delivered was measured on each occasion. The
standard deviation of the dose delivered for each irradiation protocol was less than
5%. The uncertainty in the absolute irradience measures was +/- 10%.
2.2.2 y-irradiation.
•*137Cells were y-irradiated in tissue culture flasks at 20.7Gy per minute using a Cs
source. Cells were transported to and from the irradiation source, a journey of
between 25 and 35 minutes, in an insulated container.
2.2.3 Drug treatments.
Stock solutions of Etoposide (Sigma) and Camptothecin (Sigma) were prepared in
DMSO under sterile conditions. Working strength dilutions were then made in
normal growth media. In high enough concentrations DMSO is itself toxic.
Concentrations were therefore kept below toxic levels and as low as possible. In
addition, controls containing the same percentage ofDMSO as that in the drug
dilutions were included in each experiment.
2.2.4 Preparation of cells for acridine orange counting.
Acridine orange is a metachromatic fluorochrome that differentially stains double-
stranded versus denatured DNA. The dye is an intercalating agent that, on excitation
with UVC light, emits green light when bound to double-stranded DNA and red light
when bound to denatured DNA. The nucleus of a stained cell thus appears green
under UVC light whilst the cytoplasm stains red. This staining allows for the
examination of nuclear morphology and hence the detection of cells undergoing
apoptosis.
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At selected time points after irradiation or drug treatment, cells were trypsinised and
centrifuged. together with the medium and PBS from the pre-trypsinisation wash.
The supernatant was discarded, cells resuspended in PBS and two volumes of ice
cold fix (90% ethanol, 10% formaldehyde) added. Cell suspensions were stored at
4°C until counted. Before counting, cells were centrifuged at 220 x g for 10 minutes
at 4°C, resuspended in 5ml PBS, spun again and finally resuspended in 50 to lOOOpl
of PBS (depending on cell density). 15pi of cell suspension was dropped onto a
clean glass slide, and an equal volume of acridine orange solution (lOmg/ml, Sigma)
dropped onto a coverslip. The coverslip was carefully lowered onto the slide, and the
preparation scored for apoptosis, on the grounds of nuclear morphology, under a
fluorescence microscope (Leitz). To determine the minimum number of cells that
needed to be scored in order to obtain an accurate estimate of the levels of apoptosis,
550 cells were scored and the results plotted as a running mean (see Figure 5). From
this graph, a count of 250 cells was selected as an appropriate estimate and used
henceforth.
2.2.5 Preparation of cells for flow cytometry.
Cells were prepared for flow cytometry according to the method of Vindelov et al.
(1983). Cells were trypsinised, again retaining the medium and PBS wash, spun
down (100 x g, 5 min.) and resuspended in PBS at 107cells/ml. Aliquots of 100pl
were frozen at -70°C prior to analysis. After thawing, 450pl of a cell lysis solution
(solution A, see appendix I) was added to the aliquot, mixed gently and incubated at
room temperature for 20 minutes. This solution was then neutralised by incubation
for 10 minutes at room temperature with 325pl of solution B (see appendix I).
Finally, cells were stained by the addition of 250pl of propidium iodide solution
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Figure 5: Running mean of percetage apoptosis against cell count.
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2.2.6 Flow cytometry7.
Analyses were performed on a Coulter EPICS-XL flow cytometer at an excitation
wavelength of 488nm. On each occasion of use, the alignment of the laser was
checked using Immuno-Check (Coulter) alignment fluorospheres, and half-peak
coefficients of variation were less than 2%. Cells were analysed according to
forward and side scatter and doublet compensation was performed. At least 10,000
nuclei were analysed in each sample, and the proportion of apoptotic cells estimated
as the proportion of cells having a DNA content less than that observed in the G0/Gi
peak. The cut off point between the Go/Gi peak and the hypodiploid peak was
defined as the low point closest to the base of the Go/Gi peak that showed a count of
less than five fluorescent bodies. Bodies having a DNA content less than 12.5% of
the Gi DNA content were assumed to be debris or small apoptotic bodies and were
excluded from the analysis. A typical analysis, showing protocols and gating, is
shown in Appendix III.
2.3 Chromosomal analyses.
2.3.1 Preparation of metaphase spreads for chromosome counting and FISH
analyses.
Cultures were fed 24 hours before harvesting to achieve partial synchronisation.
Cultures were harvested when approximately 50% confluent and thus in log phase
growth. Two hours before harvesting colcemid (Boehringer Mannheim) was added
to the culture medium to a final concentration of 0.1 pg/ml. Following the two hour
incubation, cells were trypsinised following the usual protocol and centrifuged at 100
x g for 5 minutes. The cells were then gently resuspended in 0.075M KC1 and
incubated for four minutes at room temperature. Cells were again centrifuged and
gently resuspended in a single drop of supernatant before fixing by the addition of
10ml of ice-cold fix (60% methanol, 40% glacial acetic acid). The cell suspension
was incubated on ice for 30 minutes, centrifuged and resuspended in 5ml of fresh fix.
After a five minute incubation, the cell suspension was spun again and resuspended
55
in a small volume of fix (depending on the cell density). Slides were prepared by
washing in 70% ethanol, rinsing thoroughly in tap water and storing in DDW. Three
drops of the cell suspension was dropped onto each slide from a height of
approximately 40cm. and the slides air dried. Slides were stored in a dessicator and
used within one month.
2.3.2 Chromosome counts.
For chromosome counts, slides were stained in 5% Giemsa prepared in PBS. Thirty
metaphase spreads were selected at random and the number of chromosomes counted
in each spread.
2.3.3 FISH analyses.
Fluorescent in-situ hybridisation (FISH) analyses were performed using a
biotinylated murine chromosome 11 paint (Cambio) according to the technique of
Fantas et al. (1992). Chromosome paints are prepared from PCR amplified DNA
obtained from a single chromosome which has been purified using fluorescence
activated chromosome sorting, and are thus specific to an entire chromosome rather
than a single locus. Slides were warmed at 60°C for 30 minutes and then denatured
in 70% formamide (see appendix I) at 65°C for two minutes. Slides were
immediately transferred to ice-cold 70% ethanol for two minutes and then through
90% and 100% ethanol (also on ice) for two minutes each. Slides were air dried.
After being prewarmed to 42°C and briefly vortexed, the chromosome paint was
denatured at 70°C for 8 minutes and pre-annealed at 37°C for 15 minutes. Whilst
the paint was pre-annealing, slides and clean coverslips were prewarmed to 37°C.
15pi of the paint was pipetted onto each coverslip, and the coverslips lowered onto
slides and sealed with rubber solution. Slides were incubated overnight at 37°C. The
rubber seal was removed from the coverslip and the coverslip allowed to fall off in
the first wash. Slides were washed four times, for three minutes each in the first
wash (2x saline sodium citrate buffer (SSC), 50% formamide) at 45°C. This was
repeated with the second wash (2xSSC). Slides were then transferred to 4xSSC,
0.1% Tween 20. Freshly prepared, 40pl aliquots of avidin FITC, biotinylated anti-
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avidin and blocking buffer (see appendix I) were spun for 15 minutes at 4°C to
remove antibody conjugates. Each slide was incubated for five minutes, at room
temperature, with 40pl of blocking buffer. From this point on. care was taken that
the slides did not dry out at any stage of the labelling process. The blocking buffer
was drained from the slide and replaced with 40pl of avidin FITC, and the slide
incubated for 30 minutes at 37°C. Slides were washed three times, for two minutes
each in 4xSSC, 0.1% Tween 20, at 45°C. The slide was then incubated for 30
minutes, at 37°C with 40pi of biotinylated anti-avidin. The wash process was
repeated, and the slide incubated for a further 30 minutes with 40pi of avidin FITC.
Finally, the slides were again washed and mounted with 40pl of vectormount (see
appendix I). The slides were examined using the Apple Macintosh-based
quantitative image analysis software Macprobe (Perceptive Scientific Instruments
Ltd.). This system uses a fluorescence microscope (Leica) equipped with a charged
coupled device camera and P-l filter set (Chroma Technologies). Each fluorochrome
is excited separately using a single band-pass excitation filter and grey-level images
are captured at xlOOO magnification, overlaid and displayed in pseudo-colour. One
hundred metaphase spreads were selected at random and the number of stained
chromosomes counted in each spread.
2.4 p53 analyses.
2.4.1 Preparation of cytospins.
After trypsinisation, cells were centrifuged at 100 x g for five minutes, the
supernatant removed and cells resuspended in PBS at 2 x 106/ml. Cytospins were
prepared using a Shandon Cytospin 2, Shandon 190005 filter cards and Blue Star
slides (Chance Propper Ltd). 100pl of cell suspension was placed in the cytospin
chamber and spun onto the slides at 300rpm for 3 minutes. Slides were then air dried
and fixed (in 50% methanol, 50% acetone) at 4°C for 5 minutes. Slides were tightly
wrapped and stored at -20°C until use.
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2.4.2 p53 immunocytochemistry.
The rabbit polyclonal antibody CMS (Novacastra Laboratories), which is specific for
murine p53, was used to detect the induction of p53 subsequent to DNA damage.
Slides were placed in Tris buffered saline (TBS, see appendix I) for five minutes.
Endogenous peroxidase activity was then blocked by incubating slides for 10 minutes
in 3% hydrogen peroxide (Sigma). Slides were rinsed twice in TBS and then washed
for five minutes in a third rinse of TBS. Sufficient normal swine serum (NSS, see
appendix I) was dropped onto each slide to cover the cells, and slides were incubated
for 10 minutes at room temperature. Excess serum was drained from the slide and
replaced with the primary antibody (diluted 1:1000 in NSS), and the slides incubated
for one hour in a humidified chamber at room temperature. Slides were rinsed and
then washed twice, for five minutes each, in TBS. The biotinylated swine-anti-rabbit
secondary antibody (Dako) was diluted 1:500 in NSS and incubated on the slides for
30 minutes, in a humidified chamber, at room temperature. Slides were again rinsed
and washed twice in TBS. Finally, slides were stained with the Dako ABC E1RP kit
according to the manufacturers instructions. This kit utilises an avidin and biotin
conjugated horseradish peroxidase enzyme complex (ABC). Slides were washed in
running water and counter-stained Harris's haematoxylin (Life Science) for seven to
10 seconds. Before mounting in Pertex (Cell Path PLC), slides were dehydrated by
two minute incubations in, 64%, 74% and 100% bench alcohol.
2.4.3 Protein sample preparation.
After trypsinisation, cells were centrifuged at 100 x g for five minutes and the
supernatant removed. Cells were counted and resuspended in PBS . Samples were
snap frozen in aliquots of 106 cells and stored at -70°C until use. Upon thawing,
samples were washed in PBS, spun down and resuspended in 20pl of lysis buffer (see
appendix I). Genomic DNA was sheared by passing the sample through a 23 gauge
hypodermic needle or by sonication for 30 minutes, at 37°C. Protein concentrations
were calculated using the Bio-Rad protein assay. A 5pl sample of lysate was added
to 1ml of the Bio-Rad reagent, incubated at room temperature for five minutes and its
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optical density measured at 595 nm. A number of protein standards of known
concentration were measured at the same time and a calibration curve plotted. The
protein concentration of samples was determined by comparison to the standard
calibration curve. Protein samples were kept on ice during processing and stored at -
70°C.
2.4.4 Protein electrophoresis and western transfer.
Protein samples were separated on vertical, polyacrylamide gels using the Bio-Rad
Mini-Protean II system. One mm thick, 12.5% running gels were prepared (see
appendix I) with a 4% stacking gel (see appendix I) and placed in the electrophoresis
apparatus with tank buffer (see appendix I). An equal volume of running buffer (see
appendix I) was added to 7 pi of protein sample and incubated at 100°C for two
minutes. Samples were placed on ice and then loaded on the gel alongside a pre-
stained protein molecular weight standard (Gibco). Samples were then
electrophoresed at 30mA per gel until the dye front reached the bottom of the gel.
Western transfers were prepared using the Hoefer semi-dry system. The gel
apparatus was disassembled and the stacking gel removed. The gel was incubated in
transfer buffer (see appendix I) for 10 minutes. Six sheets of Whatman 3MM paper
were soaked in transfer buffer and placed on the anode base of the transfer unit. A
piece of Highland ECL membrane (Amersham), cut to the size of the gel, was soaked
in DDW and placed on top of the 3MM paper. The gel was placed on top of the
membrane and three more sheets of 3MM, again soaked in transfer buffer, placed on
top. Bubbles were removed by gently rolling with a glass pipette. The gels were
transferred in pairs, at 400mA, for 30 minutes. Efficient transfer of proteins was
confirmed by staining membranes for 10 minutes in Ponceau S (Sigma). Membranes
were rinsed three times in DDW and photographed before de-staining in DDW.
2.4.5 p53 immunohistochemistry.
Non-specific protein binding sites were blocked by incubating the membrane in
TBST (tris-buffered saline with Tween, see appendix I) containing 5% w/v
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powdered, skimmed, milk for a minimum of one hour. The membrane was then
incubated overnight, at 4°C, with the rabbit polyclonal antibody CM5 (Novacastra
Laboratories) at a dilution of 1:1000. The membrane was washed three times, for
five minutes each, whilst agitating gently, with TBST. The membrane was
transferred to a 1:1000 dilution of secondary antibody (horseradish peroxidase
conjugated donkey anti-rabbit, Amersham) and incubated for one hour, at room
temperature. Finally, the membrane was washed three times, for 10 minutes each, in
TBST. Antibody binding was visualised using the ECL detection kit (Amersham)
according to the manufacturers instructions. This detection system is based on the
oxidation, under alkaline conditions, of luminol by the peroxidase conjugated to the
secondary antibody. Decay of the oxidised luminol results in the emission of light
which can be detected by autoradiography using blue-light sensitive film (Hyperfilm,
Amersham).
2.5 Southern analyses.
2.5.1 Preparation of high molecular weight genomic DNA.
In most instances, high molecular weight genomic DNA was prepared from cell
pellets containing approximately 1 x 106 cells. Cells were resuspended in 500pl of
lysis buffer (see appendix I) and 30pl of proteinase K solution (20mg/ml) added.
The lysates were then shaken in an orbital shaker, at 220rpm, at 37°C, overnight. An
equal volume of phenol was added to the lysate, the tube inverted several times and
briefly spun down. The upper, aqueous phase was carefully removed leaving behind
any precipitates formed at the boundary between the two phases. The phenol
extraction was repeated and two chloroform (see appendix I) extractions performed
in a similar way. The DNA was precipitated from the resulting solution with an
equal volume of propan-2-ol, lifted out of the tube with a sterile pipette tip and
placed in a fresh tube containing 70% ethanol. The DNA was then centrifuged at
13,000rpm, in a bench-top microfuge, for 15 minutes. The ethanol was drained from
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the tube, and the DNA air dried for 30 minutes. Finally, the DNA was dissolved in
60fil of tris/ethylenediaminetetraacetic acid (EDTA) buffer (TE, see appendix I).
Occasionally, DNA was prepared from solid tissue. The tissue (approximately
lOOmg) was finely chopped, with a scalpel, in a petri dish containing 5mls of
sodium/tris/EDTA buffer (TNE, see appendix I). The resulting cell suspension was
centrifuged at 1000 x g, for 15 minutes and resuspended in lOmls of TNE. Sodium
dodecyl sulphate (SDS) was added to a final concentration of 0.5% (W/V), and
proteinase K to a concentration of 50pg/ml. The cell suspension was then incubated
at 50°C for one hour. One phenol extraction was performed and the aqueous phase
removed with a wide bore pipette. A second extraction was similarly performed with
chloroform. DNA was precipitated by the addition of two volumes of pure ethanol
and spooled out with a sealed pasteur pipette. The pellet was washed with 70% and
then 100% ethanol, and air dried for 2-3 hours. The DNA was dissolved in TE and
the concentration and purity determined spectrophotometrically.
2.5.2 Restriction endonuclease digestion and agarose gel electrophoresis of high
molecular weight genomic DNA.
Genomic DNA samples (10-15ptg) were digested with appropriate restriction
endonuclease enzymes using the incubation buffer and reaction conditions supplied
by the manufacturer (Life Technologies). Spermidine was added to a final
concentration of 3mM, and 2-10 units of enzyme used per fig ofDNA digested.
Digestions were performed at 37°C, overnight, and then stored at 4°C until
electrophoresed. After the addition of tracking dye (see appendix I), samples were
electrophoresed alongside DNA molecular weight markers (X Hindlll fragments, Life
Technologies) in 0.6-0.8% horizontal, submarine, agarose gels (see appendix I). Gels
were run at 4°C, for 16 hours, at 65V.
2.5.3 Southern transfer of DNA fragments to nylon membranes.
After electrophoresis, gels were stained for 30 minutes in 0.5|ig/ml ethidium bromide
and photographed under UV light. The DNA marker lanes were trimmed from the
gel and the gel depurinated for 15 minutes in 0.25M HC1. The gel was then
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denatured in alkali buffer (see appendix I) for one hour, at room temperature, with
gentle agitation. The alkali buffer was neutralised by gently agitating the gel in
neutralising buffer (see appendix I) for one hour. The gel was then transferred to
lOxSSC (see appendix I) while the transfer was constructed. Half a box ofKleenex
tissues were placed in the bottom of a plastic tray and covered with several layers of
Grade I Whatman filter paper. Two sheets of filter paper soaked in lOxSSC were
placed on top of the dry sheets and the nylon membrane (Hybond-N, Amersham),
also soaked in lOxSSC, placed on top of these, taking care to exclude bubbles. The
gel was then placed on top of the membrane, again excluding bubbles, and covered in
another sheet of pre-soaked filter paper which had been cut to the size of the gel. A
synthetic sponge was immersed in lOxSSC and allowed to drain until drips no longer
fell from the sponge when held horizontal. This was placed on top of the last sheet
of filter paper, and the entire apparatus sealed in a polythene bag and left overnight.
The apparatus was then dismantled and the membrane rinsed in 3xSSC. DNA was
bound to the membrane by baking at 80°C for two hours.
2.5.4 DNA probes.
The recombinant plasmid pCPR4.1 (Purdie, 1993), which contains both 5' and 3'
regions of the p53 gene sequence, was digested with Hindll and the 2kb fragment
(containingp53 exons 10 and 11) purified (see section 2.5.5) and used as a DNA
probe. The neo probe was a 600bp, PstI fragment derived from the recombinant
plasmid pMCl-Neo (Thomas and Capecchi, 1987). The Hprt polymerase chain
reaction (PCR) product derived from complimentary DNA (cDNA) of the ES cell
line E14 (see sections 2.6.1 to 2.6.3) was used as a probe for Hprt.
2.5.5 DEAE membrane purification of DNA fragments for DNA probes.
DNA fragments were purified for use as probes using DEAE (Schleicher and
Schuell) membrane according to Sambrook et al. (1989). Briefly, the DNA was
digested with the appropriate restriction enzyme and electrophoresed in an agarose
gel (see section 2.5.2). A slit was cut in the gel, just in front of the required band,
and a piece ofDEAE membrane placed in the slit. The band was electrophoresed
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onto the membrane and then eluted from it by incubating at 65°C, for one hour, in a
high salt buffer (50mM Tris, ImM EDTA, 1M NaCl, pH 9.0). The resulting DNA
solution was extracted once with phenol:chloroform and then precipitated with
ethanol (see section 2.5.1). The DNA was centrifuged at 13.000rpm, in a bench-top
microfuge, for 15 minutes. The ethanol was drained from the tube and the pellet
washed in 70% ethanol. The DNA was again centrifuged for 15 minutes at
13,000rpm, the ethanol removed and the DNA air dried for 30 minutes. Finally, the
DNA was dissolved in TE and quantitated spectrophotometrically.
2.5.6 Labelling of DNA probes.
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DNA probes were labelled with a P deoxycytosine triphosphate (dCTP) using the
random priming method. The Prime-It RmT kit (Stratagene) was utilised for this
purpose and used according to the manufacturers recommended protocol. In
summary, 50ng of probe was added to a single-use reaction tube containing random
primers, nucleotides, buffer and co-factors for use with a32PdCTP and denatured by
boiling for 5 minutes. To this tube was added 50gCi of a32PdCTP (ICN) and 12 units
ofDNA polymerase, and the contents incubated at 37°C for 30 minutes. After this
time the reaction was terminated by the addition of 2gl stop mix (0.5M EDTA,
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pH8.0). Unincorporated a PdCTP was removed with a Sephadex G-50 nick column
(Pharmacia), used according to the manufacturers instructions. The column was
rinsed with TE and equilibrated by allowing 3ml of TE to pass through the column.
The labelled DNA probe was added, along with 400gl TE, and allowed to pass into
the column bed. The probe was then eluted from the column by the addition of a
further 400gl of TE and collected in an eppendorf. An approximate measure of
isotope incorporation into the probe was obtained by comparing the Geiger counter
reading of the tube relative to the column.
2.5.7 Hybridisation of labelled DNA to Southern transfers and post-
hybridisation treatment.
Southern transfers were placed, DNA side up, on a sheet of fine nylon mesh, rolled
and placed in a Hybaid hybridisation bottle. The bottle was filled with 3xSSC and
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tapped to remove bubbles. An aliquot of sonicated salmon sperm DNA (Sigma) was
denatured by boiling for five minutes and added to hybridisation buffer (see appendix
I) at a concentration of 100pg/ml. The 3xSSC was removed, and replaced with
15mls of hybridisation buffer. The hybridisation bottle was placed in a Hybaid Mini
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10 hybridisation oven, and prehybridised for four hours at 65°C. The a "PdCTP
labelled DNA probe (see section 2.5.6) was denatured, by boiling for five minutes,
and added to the hybridisation bottle. The bottle was then incubated overnight, at
65°C.
Post-hybridisation wash solutions were prewarmed to 65°C. The hybridisation buffer
was removed from the bottle and the bottle rinsed with 200ml ofwash 1 (see
appendix I). A second aliquot of 200ml of wash 1 was added to the bottle and
incubated for 10 minutes at 65°C, in the Hybaid oven. This wash was repeated once.
200ml of wash 2 (see appendix I) was added to the bottle, and the bottle incubated
for two hours at 65°C. This wash was repeated, and then the bottle rinsed twice with
2xSSC. The filter was removed from the bottle and sealed in cling-film. The sealed
filter was placed in an X-ray cassette (Hypercassette, Amersham) containing two
Hyperscreen (Amersham) intensifying screens and a sheet of Kodak X-OMAT film,
and exposed at -70°C for 1-10 days. The exposed film was developed in an
Hyperprocessor (Amersham International pic) automatic film developer. After
autoradiography, the filter was stripped of hybridised probe by placing in a boiling
solution of 0.1% SDS, in which the filter was left to cool to room temperature.
2.6 Hprt mutation spectrum analysis.
2.6.1 RNA preparation.
In order to avoid contamination with RNAase, pre-packaged filter tips and sterile,
disposable plastic-ware were used. RNase-free DDW, prepared using the Elga
Maxima system (Elga), was used. Gloves were worn at all times and care was taken
not to touch any surfaces that would come into contact with the RNA preparation.
The phenol based Trizol reagent (Life Technologies) was used for RNA extractions.
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Log phase cells (approximately 3 x 106) were lysed, in their culture dish, by the
addition of 2ml of Trizol. The lysate was split into two Eppendorfs and incubated for
five minutes at room temperature before the addition of 200pl of chloroform and
300pl ofDDW. The homogenised samples were vortexed and then incubated for a
further three minutes. The samples were centrifuged at 13,000rpm in a bench-top
microfuge for five minutes and the upper aqueous phase removed. If the aqueous
phase was slightly cloudy, an extra chloroform extraction was performed using an
equal volume of chloroform. RNA was precipitated from the sample by the addition
of 0.5ml propan-2-ol and incubation at -70°C, for 1 hour. The RNA samples were
centrifuged, at 13,000rpm, in a microfuge for 10 minutes at 4°C, washed in 200pi of
70% ethanol and air dried for 30 minutes. The RNA was dissolved in lOOpl of
DDW, and stored, in aliquots, at -70°C. The concentration and purity ofRNA
samples was determined spectrophotometrically.
2.6.2 cDNA preparation.
A 2pg aliquot ofRNA was defrosted on ice and 0.5ng of oligo(dT) primers (Life
Technologies) added. The mixture was heated to 72°C for 10 minutes and
transferred to ice for 1 minute. To the tube were added 2gl PCR buffer (Life
Technologies), 2jul of lOpM mixed dNTPs (deoxynucleoside triphosphates, Life
Technologies), 2|ul 0.1M dithiothreitol (DTT, Life Technologies), lpl (200U) ofM-
MLV reverse transcriptase (Life Technologies) and sterile DDW to a final volume of
20pl. The tube was incubated at 37°C for one hour and the reaction terminated by
heating to 80°C for 15 minutes. Samples were stored at 4°C.
2.6.3 The polymerase chain reaction.
Two PCRs were performed on each cDNA sample using the same PCR conditions
and reagents. The first reaction was designed to amplify an 832 bp fragment
encompassing the entire coding sequence of the Hprt gene. As the samples analysed
were derived from cell lines assumed to be bearing y-irradiation induced Hprt
mutations (see section 2.1.7), it was predicted that a proportion of the samples would
have large deletions in or around the region of the Hprt gene, and thus might not
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produce a PCR product. The second reaction was therefore designed as a control to
ensure that the absence of an Hprt PCR product was due to the deletion of a primer
site and not a poor cDNA preparation or PCR. The control reaction was designed to
amplify a 1265 bp region of the Tbpl gene, a constitutively expressed ATPase. All
PCR reactions were repeated at least once. Sequences (5? to 3') of PCR primers are
given in Table 1.






Reactions were carried out in 0.5ml eppendorf tubes on an Omnigene thermocycler
(Hybaid). Each reaction contained 200pM of each dNTP (Pharmacia), lpM of each
primer (Oswel), 1.5mM MgC^CLife Technologies), 1 unit Taq DNA polymerase
(Life Technologies), lx PCR buffer (Life Technologies) and 2pl of cDNA template
(see section 2.6.1). The reaction volume was made up to 50pi with DDW and 50pl
of paraffin oil was overlaid to prevent evaporation. Reactions were denatured at
94°C for three minutes and then 30 cycles of amplification were carried out with each
cycle consisting of 45 seconds of denaturation at 95°C, 30 seconds annealing at 60°C
and one minute, 30 seconds extension at 72°C. Reactions were visualised on a 1%
agarose gel (see section 2.5.2).
2.6.4 Sequencing of PCR products.
Direct sequencing of PCR products was carried out using the Thermo Sequenase
radiolabeled terminator cycle sequencing kit (Amersham) according to the
66
manufacturers instructions. This method of cycle sequencing utilises [a-
JJP]dideoxynucleotide (ddNTP) terminators in conjunction with a thermostable DNA
polymerase. Because only properly terminated DNA chains are labelled, "stop"
artefacts and most background bands are eliminated.
Prior to sequencing, excess dNTPs and PCR primers were removed by incubating 5 pi
of PCR product with 10 units of exonuclease I (Amersham) and two units of shrimp
alkaline phosphotase (Amersham), at 37°C for 15 minutes. The reaction was
terminated by incubation at 80°C for 15 minutes. An aliquot of untreated PCR
product was quantitated by agarose gel electrophoresis and comparison against a
quantitative marker.
A 2pi aliquot of dGTP termination master mix was mixed with 0.5jul of [a-
P]ddNTP to produce a termination mix for each ddNTP. A reaction mixture was
made for each sample by mixing 25fmol (usually l-5pl) of PCR product with lpmol
sequence-specific primer (either HPRT1 or HPRT2) and 2pl reaction buffer, in a final
volume of 20pl. 4.5pl of reaction mixture was transferred to each termination tube,
mixed and overlaid with one drop of paraffin oil. The tubes were placed on a thermal
cycling block and amplified under the same conditions as the original PCR reaction
(see section 2.6.3). Stop solution (4pl) was added to each tube and the samples
heated to 70°C for 2 minutes before loading 3 pi per lane onto a denaturing
polyacrylamide gel.
2.6.5 Sequencing gel electrophoresis.
Sequencing was carried out on BRL S2 (Life Technologies) sequencing apparatus
using 0.4mm spacers and sharks-tooth combs. Plates were washed thoroughly and
wiped with 70% ethanol before use. Immediately before pouring, 60ml of gel stock
solution (see appendix I) was polymerised by the addition of 60pl 25% ammonium
persulphate (Life Technologies) and 60pl TEMED (Fisher). The gel was allowed to
polymerise, horizontally, for 1 hour with inverted combs. The gel was then pre-run
in glycerol tolerant gel buffer (USB), without combs, for 30-60 minutes at 90W, until
it reached 50°C. The combs were replaced to form wells, which were rinsed
67
thoroughly with running buffer. Samples were heated to 75°C for 3 min prior to
loading and run for 2-6 hours at 80W. The gel was fixed twice in 10% acetic acid
10% methanol for 5 minutes and transferred onto 3MM paper. Finally, the gel was
dried for 2 hours on a vacuum gel dryer (Bio-Rad) and exposed to Kodak Biomax-
MRI film overnight.
2.7 Statistical methods.
All statistical analyses were performed using the statistical computer package
Minitab Release 11 (Minitab ). Datasets were tested for normal distribution and






The immediate response to DNA damage in ES cells.
3.1.1 The apoptotic response to DNA damage in ES cells.
In order to determine the response of ES cells to a variety of stimuli, ES cells were
exposed to a number ofDNA-damaging agents. These included the topoisomerase II
inhibitor etoposide, the topoisomerase I inhibitor camptothecin, UVC-irradiation and
y-irradiation (see chapter 2, section 2.2 for a discussion of the types of DNA-damage
induced by these agents). In the first instance, cells were stained with acridine orange
and apoptotic cells recognised by their condensed and often fragmented chromatin.
This method of detection allows a definitive assessment of the proportion of
apoptotic cells based on their nuclear morphology but, although widely accepted, it is
time consuming. Therefore, a flow cytometric method based on the proportion of
cells having a DNA content less than that observed in the Go/Gi peak (the
hypodiploid peak) was also used. The accuracy of this estimate was confirmed by
comparison to direct measurements based on nuclear morphology. In this
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comparison, cells were irradiated with 17J/m UVC and the irradiated cells divided
into two aliquots, one to be analysed by morphometric criteria following acridine
orange staining and the other by flow cytometry (Figure 6). A statistical analysis
showed a high correlation between these two methods (Pearson correlation
coefficient = 0.929). A similarly high correlation was seen between flow cytometric
and morphometric data obtained after y-irradiation.
3.1.1.1 The apoptotic response to Camptothecin.
Wild-type (CGR8) ES cells were exposed to Camptothecin levels ranging from 0.01
to lpM and cells harvested for acridine orange counts at 0, 12, 24, 36 and 48 hours.
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Figure 6: A: Kinetics of the induction of apoptosis in response to 17J/m2UVC. Solid
symbols reprersent treated ES cells (El4) and open symbols mock-treated controls.
Circles represent estimates obtained by flow cytometry and squares the same cells
stained with acridine orange and counted directly. B: DNA histogram ofmock-treated
ES cells 24hrs subsequent to treatment. C: DNA histogram of ES cells treated with
17J/m2 UVC 24hrs after treatment.
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All treatments were performed in duplicate. Only the highest dose used (lpM)
induced apoptosis to any significant degree (Figure 7). Elevated levels were first
observed at 36 hours and continued to rise to a maximum of 85% at 48 hours.
3.1.1.2 The apoptotic response to Etoposide.
ES cells (CGR8) were exposed to a variety of concentrations of etoposide ranging
from 0.2 to 20pM and cells harvested for acridine orange counts at 0, 12, 36 and 48
hours. All treatments were performed in triplicate. Very little apoptosis was seen in
the DMSO controls and the lowest dose (0.2pM) of etoposide used. In the two
higher doses (2pM and 20pM), substantial numbers of apoptotic cells were seen at
the 36 hour time-point, and this proportion had increased still further by 48 hours
(Figure 8).
3.1.1.3 The apoptotic response to UVC-irradiation.
El4 cells were exposed to UVC-irradiation (in triplicate) over a dose range of 23 to
1100J/m2. Cultures were observed by phase contrast microscopy after 20 hours and
appreciable levels of cell death were visible in all but untreated controls. Cultures
were therefore harvested for acridine orange counts at 24 hours. A log linear
relationship was observed between UVC dose and apoptosis (Pearson correlation
coefficient between percentage apoptosis and log'°(dose) = 0.903; Figure 9).
A UVC dose of 93J/m , which induced 55% apoptosis at 24 hours, was used to
investigate the kinetics of the induction of apoptosis. Cell cultures, again in
triplicate, were harvested at time-points ranging from 0 to 40 hours. Elevated levels
of apoptosis were seen as little as four hours after irradiation and continued to rise,
reaching a plateau at 24 hours (Figure 10). Similar levels of apoptosis were observed
with a UVC dose of 17J/m2 (Figure 6) but at this dose the kinetics of induction were
slightly slower, peaking at 36 hours.
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Figure 7: Kinetics of the induction of apoptosis in wild-type ES cells (El4) in response
to a range of doses of camptothecin. Circles, 0.2% DMSO control; squares, 0.0 lpM
camptothecin; upward pointing triangles, 0.1 pM camptothecin; downward pointing
triangles, 1 uM camptothecin. Each data point represents the mean of two duplicates and
error bars indicate the range.
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Figure 8: Kinetics of the induction of apoptosis, in wild-type ES cells (El 4), in response
to a range of doses of etoposide. Circles. 0.2% DMSO control; squares, 0.2pM
etoposide; upward pointing triangles, 2pM etoposide; downward pointing triangles,
20pM etoposide. Each data point represents the mean of three replicates and error bars
indicate the standard error.
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Figure 9: Dose response of apoptosis 24 hours after UVC-irradiation in wild-type ES
cells (El4). Each data point represents the mean of three replicates and error bars
indicate the standard error.
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Figure 10: Kinetics of the induction of apoptosis in wild-type ES cells (El4)
subsequent to 93J/m2 UVC-irradiation. Open symbols, mock-treated controls; closed
symbols, irradiated cells. Each datapoint represents the mean of three replicates and
error bars indicate standard errors.
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3.1.1.4 The apoptotic response to y-irradiation.
Duplicate cultures of E14 cells were exposed to y-radiation doses ranging from 3.6 to
19Gy and harvested after 0. 24 48 and 72 hours. The level of apoptosis was assessed
by acridine orange staining. Even at the highest dose of 19Gy, levels of apoptosis
were low (less than 40%) relative to those observed after both UVC-irradiation and
topoisomerase inhibitors (Figure 11). In addition, the onset of the induction of
apoptosis appeared to be delayed and levels were still rising at 72 hours. Because of
the effect of cellular proliferation on the denominator, it was not possible to extend
the time-course beyond 72 hours using this method of detection. Two further
experiments, using flow cytometry, to examine the kinetics of apoptosis after y-
irradiation (7.6Gy) revealed little or no induction of apoptosis (Figures 12 and 13).
These findings were unexpected and led to concerns over the degree of variation in
levels of apoptosis between the experiments. To address this issue, three more time-
courses were performed (in duplicate) and analysed by flow cytometry. A strong
induction of apoptosis was not seen in any of the experiments but variation between
experiments was relatively high (Figure 14). In all three experiments, levels of
apoptosis were consistently slightly higher in irradiated cells but a statistical analysis
of the entire data-set showed that this difference was not significant (Analysis of
Variance (ANOVA), p=0.092).
3.1.1.5 The effect of varying levels of confluence on the apoptotic response to
UVC-irradiation
Levels of apoptosis induced after DNA-damage were often quite variable between
experiments (see sections 3.1.1.4 and 3.2.2.2). In an attempt to determine the source
of this variation, the effect on the induction of apoptosis of variations in confluence
levels of cells immediately prior to treatment was examined. In each of the previous
experiments, the confluence level of cells to be treated was not accurately controlled
between experiments. To investigate the effect of this parameter on apoptosis, cell
cultures were seeded at varying densities, irradiated with 17J/m2 UVC and harvested
for flow cytometry 24 hours later. Cell counts were obtained, at the time of
irradiation, from control cultures seeded at the same density as cultures to be treated.
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Figure 11: The kinetics of the induction of apoptosis in wild-type ES cells (E14) in
response to a range of doses of y-irradiation. Squares, unirradiated control; circles,
3.8Gy; upward pointing triangles, 7.6Gy; downward pointing triangles, 19Gy. Each
data point represents the mean of two replicates and error bars indicate the range.
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Figure 12: Kinetics of the induction of apoptosis in wild-type ES cells (E14) following












Figure 13: Kinetics of the induction of apoptosis in wild-type ES cells (El 4) following




Figure 14: Kinetics of the induction of apoptosis in wild-type ES cells (El 4) following
7.6Gy y-irradiation. Open symbols, mock-treated controls; closed symbols, irradiated
cells. Each datapoint represents the mean of three experiments and error bars indicate
the standard error.
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In total, four experiments were performed. Although it was not possible to
statistically test this hypothesis, all four experiments suggested a possible trend
whereby cells treated at either very low or very high levels of confluence were more
resistant to the induction of apoptosis (Figure 15). However, there was appreciable
variation in the response between experiments indicating that confluence alone could
not account for the disparity in levels of induction of apoptosis. It should also be
stressed that these experiments examined the effect of confluence on levels of
apoptosis at a single time-point and thus the possibility that confluence does not
affect sensitivity but merely changes the kinetics of the induction of apoptosis cannot
be excluded.
3.1.2 p53 induction following DNA damage.
Because of the different patterns of induction of apoptosis observed in ES cells, p53
protein expression was examined, by immunocytochemistry and western analysis,
following y and UVC-irradiation.
3.1.2.1 p53 induction following UVC-irradiation.
Following UVC (37J/m~) treatment, the proportion of cells staining positively for
p53 rose rapidly to a peak (88%) at 2 hours and returned to basal levels within 48
hours (Figure 16A). Western analysis revealed a similar rapid rise in p53 protein
levels which peaked at 4 hours and again returned to basal levels within 48 hours
(Figure 17). Mock-treated cells also showed a low amplitude, transitory p53
induction immediately after irradiation (Figure 16A). Cellular localisation of p53
was clearly nuclear (Figure 18).
3.1.2.2 p53 induction following y-irradiation.
The response to y-irradiation was more complex with two distinct phases of p53
expression (Figure 16B). Increased expression was observed, both in terms of the
proportion of positively staining cells and absolute protein levels, within one hour of
treatment and fell during the next seven hours (Figure 16B and 19). Mock-treated
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Figure 15: The effect of confluence levels of cell cultures prior to UVC-irradiation
(17J/m2) on the induction of apoptosis 24 hours after irradiation. Open symbols
represent mock-irradiated controls and solid symbols irradiated cells. The experiment
was repeated four times and each dataset is represented by a different symbol.
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Time (hrs)
Figure 16: p53 induction in ES cells (El4) following 37J/m2 UVC (A) or 7.6Gy y-
irradiation (B). Open symbols represent treated cells and solid symbols mock treated
controls. In B, points represent the mean of four counts, two each derived from two
separate time courses. Error bars represent the standard error.
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Figure 17: Western analysis of p53 expression in ES cells (El4) subsequent to
treatment with UVC. The membrane was first labelled with Ponceau S stain to confirm
uniform loading (A) and then labelled with the p53 antibody CM5 (B). MW indicates
molecular weight markers. +ve indicates proteins extracted 7 hours subsequent to UVC
irradiation (50J/m2) as a positive control, -ve indicates proteins extracted from
unirradiated cells. p53~ indicates proteins extracted from p53 null cells as a negative
control. Control indicates mock treated, unirradiated cells harvested 15 minutes after
mock treatment. All other lanes contain proteins extracted from cells irradiated with
17J/m2 UVC and harvested at the timepoints indicated (in hours) above each lane. Sizes
are indicated in kilodaltons at the side of each illustration.
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Figure 18: p53 immunocytochemistry following UVC-irradiation. Wild-type cells
(El4) were stained with the polyclonal p53 antibody CM5. A: Mock treated control 2









> > <n '
+ 1 a. + - +
- +
D























1 a. + - + - + +
Figure 19: Western analysis of p53 expression in ES cells (E14) subsequent to
treatment with ionising radiation (7.6Gy). Membranes were first labelled with Ponceau
S stain to confirm uniform loading (A and C) and then labelled with the p53 antibody
CM5 (B and D). MW indicates molecular weight markers. +ve indicates proteins
extracted 7 hours subsequent to UVC-irradiation (50J/m2) as a positive control, -ve
indicates proteins extracted from unirradiated cells. p53" indicates proteins extracted
from p53 null cells as a negative control. + indicates cells irradiated with 7.6Gy
ionising radiation and - mock-treated cells. Sizes are indicated in kilodaltons at the side
of each illustration and time since irradiation (hours) above the relevant lanes.
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cells also showed a transitory p53 induction immediately after y-irradiation. Thus it
is likely that the first phase of p53 expression observed in y-irradiated cells is a
consequence of stress due to handling. This explanation concurs with the fact that
the exposure of the cells to y-irradiation, which involved substantially more
disruptions of culture conditions than did UVC-irradiation, resulted in a higher
proportion of positive staining cells among the handling-controls. A second phase of
increased expression was observed in the cytospins at 24 hours, with basal levels
restored by 48 hours (Figure 16B). However this was not detectable in the western
analysis, indicating no large, overall increase in protein levels (Figure 19).
One or more protein bands, of higher molecular weight than p53, were seen in the
Western analysis after UVC-irradiation and, to a lesser extent, after y-irradiation
(Figures 17 and 19). The antibody used in this study (CM5) was polyclonal so it is
possible that these bands represent either another member of the growing family of
p53 homologues or perhaps a form of p53 that has undergone some type of secondary
modification. However, the same Western blots labelled with a different polyclonal
p53 antibody (Boehringer Mannheim Anti-p53-protein, pan (polyclonal BMG-1B1))
did not show these extra bands.
3.1.3 Cell cycle checkpoints following DNA-damage.
Flow cytometric analyses of cell cycle distribution following y-irradiation revealed a
G2/M arrest. This arrest, which was not observed in unirradiated controls, was
maximal within six hours of irradiation and remained elevated for at least 24 hours
(Figure 20). Even 24 hours subsequent to irradiation, when the proportion of cells
exhibiting G2/M arrest was beginning to decline, the percentage of cells in G2/M was
significantly higher in irradiated than in unirradiated cells (x2 test, p = 0.008; Table
2). Like the induction of apoptosis after y-irradiation, the proportion of cells in the
G2/M peak at 24 hours varied considerably between experiments. However, at this
time point the proportion of cells in arrest was falling rapidly so that small changes in
















































Figure 20: Flow cytometric analysis of G2 arrest in wild-type ES cells (E14)
following ionising radiation (7.6Gy). Radiation dose and time after irradiation are
given in the top, right corner of each panel.
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account for at least part of the observed variability. In agreement with previous
experiments investigating the effects of "/-radiation on the induction of apoptosis.
similar proportions of cells with a sub-Gt DNA content were observed in irradiated
and mock treated cells (Figure 20). In UVC-irradiated cells, cell cycle distribution
did not differ between irradiated and mock treated cells.
Table 2: Comparison of the proportion of cells in G2/M in irradiated (7.6Gy) and
unirradiated cells 24 hours subsequent to treatment. Where two figures are given in a
single column they represent two replicates.
Experiment % G2/M in % G2/M in irradiated
unirradiated cells cells (7.6Gy)
1 19.5 20.8
2 22.6,21.1 52.9,32.8
3 22.1, 17.4 26.1, 50.9
4 20.2, 19.0 28.6, 26.2
Mean 20.27 34.04
Standard deviation 1.82 12.72
Summary.
In ES cells, UVC-irradiation and treatment with the topoisomerase inhibitors
camptothecin and etoposide results in a rapid induction of apoptosis. In contrast, the
apoptotic response to ionising radiation, even at high doses, was very weak and
delayed relative to that observed following UVC-irradiation and topoisomerase
inhibitors and, in some instances, did not differ significantly from controls.
Following UVC-irradiation, rapid, nuclear stabilisation of p53 occurs several hours
prior to the induction of apoptosis. Stabilisation of p53 after y-irradiation was, like
the apoptotic response, variable and late and was preceded by an early stress related
response. ES cells do respond to y-irradiation by a profound, extended G2 arrest.
89
Section two:
The involvement of p53 in the apoptotic response of ES cells.
3.2.1 The derivation and analysis of/?53-null ES cells.
Although the preceding experiments show p53 stabilisation occurs prior to apoptosis
in ES cells, definitive proof that p53 is necessary for apoptosis can be derived only
from experiments in which UVC treatment occurs in the absence of p53. To effect
this, -null ES cell lines were derived by high G418 selection (Mortensen et al.,
1992) from a heterozygote cell line (R72) with a targeted inactivation of the p53 gene
(Clarke et al., 1993).
3.2.1.1 The derivation and Southern analysis of /?5J-nuIl ES cells.
The /Cd-null cell lines (R72D5, R72D27, R72D45 and R72D54) were derived from
the heterozygous targeted cell line R72 (Clarke et al., 1993) and were rendered
homozygous by high dose selection at 1 (R72D5 and R72D27) or 2mg/ml (R72D45
and R72D54) of 100% active G418 (Mortensen et al., 1992). Following selection, 63
resistant colonies (34 selected in lmg/ml and 29 in 2mg/ml G418) were expanded
into cell lines and screened by Southern blotting. DNA was extracted from these
lines, digested with the restriction enzyme Bgl II and hybridised to a probe containing
p53 exons 10 and 11. Loss of the remaining, normal, p53 allele would result in
replacement of the wild-type 16kb fragment with an 1 lkb fragment (Figure 21;
Clarke et al., 1993). In the lmg/ml experiment colonies had been very densely
packed making it difficult to isolate monoclonaly derived resistant lines. Southern
analysis of these lines revealed that almost half the colonies (15) were likely to have
been polyclonal in origin (Figure 21). Only two of the remaining lines showed a
restriction pattern consistent with a/oJ-null genotype whilst the remainder (17)
displayed a restriction pattern not consistent with any of the expected genotypes
(Figure 21). This pattern, which included the 16kb wild-type fragment and two
additional bands of approximately 15kb and 8kb, was also observed at a high
frequency (20 of 29 lines) in the second, 2mg/ml experiment. However in this
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Figure 21: Southern analysis ofR72 sub-lines selected in high levels of G418. 1,
129 mouse DNA (+/+); 2, R72 (+/-); 3, R72D54 (-/-); 4, 5, 6 and 7, sub-lines of
polyclonal origin; 8, wild-type sub-line bearing a random integration of thep53
targeting construct. A: Southern blot labelled with a probe containing exons 10 and
11 of the p53 gene. B: The same Southern blot labelled with a probe for the
neomycin resistance gene of the p53 targeting construct. Sizes of bands (in Kb) are
given to the right of each panel.
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experiment very few selected lines (2) were of polyclonal origin and the proportion
ofp53-null lines was substantially higher (6). One possible explanation for the high
frequency of lines showing the unexpected restriction fragment pattern would be that
this pattern represents a p53 wild-type line bearing randomly integrated copies of the
p53 targeting construct. The observed restriction fragment pattern is consistent with
either the integration of two or more tandem copies of the plasmid at a single site or
integration at two different sites. In either case, the line would have an enhanced
resistance to G418, relative to the heterozygote, and if such a line were present as a
contaminant at very low frequency in the original R72 cell line, selection in high
levels of G418 would favour its growth. To establish whether or not this was the
correct explanation, a Southern blot bearing examples of all of the observed
restriction fragment patterns was hybridised to a probe for the neomycin resistance
gene contained in the targeting construct. This probe would not be expected to bind
to the largest wild-type fragment but would bind to the smaller, targeted band in p53-
null and heterozygote lines and also the two bands derived from the targeting
construct in the randomly integrated line. Consistent with the above explanation, no
bands were observed in wild-type lines, one band was observed inp53 heterozygote
and null lines and two bands, one smaller and one larger than thepiJ-null band, were
observed in the random integrant (Figure 21B). To further confirm the above
hypothesis and as the heterozygote cell line R72 would be required in future
experiments, R72 cells were subcloned and eight of the resulting clones genotyped by
Southern blotting (Figure 22). Seven of the eight clones showed restriction fragment
patterns consistent with heterozygosity at the p53 locus whilst the eighth showed the
pattern found in the random integrants observed in the two G418 selection
experiments, thus confirming its presence as a contaminant in the original R72 cell
line (Figure 22). p5J-null cell lines to be used in future experiments were also
subcloned to ensure a monoclonal origin.
3.2.1.2 Karyotypic analysis ofp53-null ES cells.
Evidence from several sources suggests that loss ofp53 permits genomic instability
and is commonly linked to aneuploidy in both normal and tumour cell types (see
92
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Figure 22: Southern analysis ofR72 subclones labelled with a probe containing
exons 10 and 11 of the p53 gene. 1, 129 mouse DNA (+/+); 2, R72 (+/-); 3, R72D5
(-/-); 4, 5, 6, 7, 8, 9 and 10, R72 subclones showing the R72 restriction fragment
pattern; 11, wild-type subclone bearing a random integration of the p53 targeting
construct. Sizes of bands (in Kb) are given to the right of the panel.
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section 1.3.6). If the /Oi-null cells derived here contained chromosomal
abnormalities, this would obviously have implications for the interpretation of any
data obtained from them. Thus, the karyotypic stability of/?55-null stem cell lines
and their parental heterozygote and wild-type cell lines was tested over 20 passages
in culture (approximately ten weeks). At the lowest passages analysed (five to nine
passages after derivation) all four null cell lines had an abnormal karyotype, three
having a modal near-diploid number of 41 (R72D5, R72D27 and R72D54) whilst
one was aneuploid (R72D45), having 67 chromosomes (Figures 23 and 24).
However, in none of the clones did this reflect continuing karyotypic instability as no
further divergence was observed over up to 15 additional passages (Figures 23 and
24). The parental cell line (El4) was found to have a diploid modal chromosome
number but also had an unexpectedly high proportion ofmetaphase spreads having a
near-diploid number of 41. This karyotype was also maintained over 20 additional
passages. Fluorescent in situ hybridisation, using a chromosome 11 paint, revealed
that the abnormal karyotypes ofR72D5, R72D27 and R72D54 were the result of
trisomy of chromosome 11 (Figure 25 and Table 3). The murine p53 gene is located
on chromosome 11, hence this result confirms the reduplication of the targeted
chromosome in the neomycin resistant cells. Trisomy of chromosome 11 was also
observed in a proportion ofmetaphase spreads from El4s at a level that would be
consistent with this abnormality being the cause of the additional chromosome seen
in some spreads (Table 3).
3.2.2 The apoptotic response in /753-null ES cells.
To assess the requirement for p53 in ES cell apoptosis, wild-type and /?53-null cells
were exposed to both etoposide and UVC-irradiation.
3.2.2.1 The apoptotic response to Etoposide in /?5J-null cells.
Wild-type (El4) andp53-null (R72D54) ES cells were exposed (in triplicate) to
doses of etoposide ranging from 0 to 20pM and harvested 26 hours later for scoring



















1 . a- l ia








L la a a^a _















<3030 31 32 33 34 35 36 37 38 39 40 41 42 43
Chromosome number
—■ iL
<3030 31 32 33 34 35 36 37 38 39 40 41 42 43
Chromosome number
Figure 23: Karyotypic analysis of wild-type, heterozygous and p53 null ES cell lines.
A: E14 (+/+) cell line at a passage equivalent to that of the p53 null cell lines five
passages after derivation. B: E14 cell line at a passage equivalent to that of the p53 null
cell lines 20 passages after derivation. C: R72 (+/-) cell line at a passage equivalent to
that of the p53 null cell lines five passages after derivation. D: R72 cell line at a passage
equivalent to that of the p53 null cell lines 20 passages after derivation. E: R72D5 (-/-)
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Figure 24: Karyotypic analysis of p53 null ES cell lines. A: R72D27 cell line six
passages after derivation. B: R72D27 cell line 20 passages after derivation. C: R72D45
cell line five passages after derivation. D: R72D45 cell line 20 passages after derivation.
E: R72D54 cell line nine passages after derivation. F: R72D54 cell line 26 passages
after derivation.
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Figure 25: Fluorescent in situ hybridisation of a murine chromosome 11 paint
showing trisomy of chromosome 11 in the p53 null ES cell line R72D5 (lOOOx
magnification).
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Table 3:. The frequency of trisomy of chromosome 11 in wild-type, heterozygote
and pod-null cell lines. For each cell line one hundred metaphase spreads were
scored for chromosome 11 trisomy.






• For clarity, passage numbers of parental cell lines are given relative to the time at
which p53-null cells were derived from them, not since the time of their own
derivation.
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were consistent with previous results (see section 3.1.1.2) and showed a clear, dose-
dependent increase in apoptosis (one-way ANOVA, p=0.000; Figure 26). In p53-null
cells, there was no induction of apoptosis, at this time-point, after exposure to the
two lower doses of etoposide (0.2 and 2uM). However, exposure to 20pM etoposide
did result in levels of apoptosis significantly higher than those observed in control
cultures (t-test. p=0.025). This partial p53-dependence of the apoptotic response to
etoposide is consistent with results previously obtained from thymocytes (Clarke et
al., 1993).
3.2.2.2 The apoptotic response to UVC-irradiation in /53-nuIl cells.
Three wild-type, p53 heterozygous and p53-null cell lines were exposed (in
triplicate) to 93J/m2 UVC and harvested for acridine orange counts after 16 hours.
Induction of apoptosis was clearly p53 dependent at this time-point; it showed near
background levels in />53-null cells and an intermediate response in p53
heterozygotes (Figure 27). A qualitatively similar response was seen 24 hours after a
lower (37J/m2) UVC dose (Figure 28). However,/*Ji-null cells still exhibited low
but significant levels of apoptosis in response to UVC indicating that p53-
independent apoptotic pathways exist in these cells (ANOVA: 93J/m~, P=0.006).
The level of apoptosis observed in wild-type cells at the higher UVC dose was less
than anticipated from previous experiments. This may reflect variations in the
kinetics of induction between experiments or variations between experiments in the
levels of apoptosis induced.
3.2.3 Cell cycle arrest in /?5J-null ES cells.
Previous experiments on cell cycle distribution of wild-type ES cells following y-
irradiation had revealed a substantial G2/M arrest peaking around six hours after
treatment (see section 3.1.3 and Figure 20). A similar investigation in/O'J-null ES
cells revealed that this arrest was p53 independent. As in wild-type cells, this arrest
was maximal within six hours of irradiation and remained elevated for at least 24




Figure 26: Induction of apoptosis in wild-type (El4) and p53 null (R72D54) cells 26
hours after treatment with etoposide. Open bars, mock-treated controls; hatched bars,
0.2pM etoposide; solid bars, 2pM etoposide; cross-hatched bars, 20pM etoposide.




Figure 27: Induction of apoptosis 16 hours subsequent to exposure to UVC in three
independent wild-type (E14, CGR8 and HMl),/?.55 hemizygous (R72-1, R72-2 and R72-
3) and null cell lines (R72D5, R72D27 and R72D54). Open bars, mock-treated controls;
solid bars, cells treated with 93 J/m2. Each bar represents the mean of three replicates and




Figure 28: Induction of apoptosis 24 hours subsequent to exposure to UVC in wild-type
(El4) p53 null cell lines (R72D27). Open bars, mock-treated controls; solid bars, cells








































Figure 29: Flow cytometric analysis ofG2/M arrest inp53-null ES cells (R72D5)
following ionising radiation (7.6Gy). Radiation dose and time after irradiation are
given in the top, right corner of each panel.
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observed in both irradiated and mock treated cultures at later time-points. A
comparison of the proportion of cells in the G2/M peak in untreated and mock-treated
controls suggests that a small G2/M arrest may also have occurred in the mock-
treated controls. A similar though smaller increase was observed in wild-type cells
(Figure 20) but in both cases it had been resolved by 12 hours (Figures 20 and 29).
This possible arrest was not investigated further but such a handling-induced arrest
would not be surprising considering the stress induced induction of p53 observed
after mock-irradiation. A comparison of the cell cycle distribution between wild-type
(Figure 20) and/?55-null ES cells (Figure 29) suggests that loss of p53 might also
affect the kinetics of the cell cycle.
3.2.4 Summary.
p53 is required for the rapid induction of apoptosis seen in ES cells after etoposide
and UVC-irradiation. However, both etoposide and UVC induce p53 independent
apoptosis. Chromosomal stability was maintained in three out of four of the y?J3-null
cell lines derived from heterozygotes by high dose G418 treatment. However, one of
the cell lines was found to be highly aneuploid suggesting the involvement of other
causative factors.
Section three:
The long term consequences of DNA damage.
3.3.1 Clonogenic survival subsequent to DNA damage.
Evasion of apoptosis in the short term does not necessarily imply a continued
capacity for growth. Therefore clonogenic survival of wild-type and pJJ-null ES
cells was examined following E1VC and y-irradiation.
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3.3.1.1 Clonogenic survival following UVC-irradiation.
Cells were exposed to UVC doses ranging from 0 to 50J/m2. Plating efficiency did
not differ betweenyoi-null and wild-type cells (t-test; df= 69. p=0.89). In both wild-
type and /?5J-null cells survival was greatly reduced, in a dose-dependent manner,
following UVC-irradiation (Figure 30A). However, survival ofyoi-null cells was
consistently higher than that of wild-type cells (Friedman test; p = 0.001).
3.3.1.2 Clonogenic survival following y-irradiation.
After y-irradiation at doses ranging from 0 to 19Gy, the clonogenic survival of both
wild-type and/o3-null cells was reduced in a dose-dependent manner (Figure 30B).
In wild-type cells, a UVC dose of 10J/m2 and a y-irradiation dose of 3.8Gy resulted
in similar levels (around 10%) of survival. Again, survival ofyOi-null cells was
consistently higher than that ofwild-type cells (Friedman test; p = 0.014).
3.3.2 Hprt mutation frequencies of wild-type and /753-null ES cells.
Even at the highest y-irradiation dose of 19Gy, up to 1.4% ofwild-type and 14.4% of
y03-null cells survived to form colonies (Figure 30B). It has been predicted that a
y03-null environment will result in an increased mutation frequency due to loss of
the normal apoptotic pathway and subsequent survival of cells bearing DNA damage.
This prompted us to investigate the mutation frequency at the Hprt locus after UVC
and y-irradiation. The assay used for this purpose measures the proportion of those
cells that survive irradiation which bear mutations in the Hprt gene, but does not
assess the effects of irradiation on cell survival.
Following UVC-irradiation, a large dose-dependent increase in mutation frequency,
up to 100-fold at higher doses, was observed. Surprisingly, the frequency inyoi-null
cells was only two-fold higher than that in wild-type cells, although this difference
was significant (Sign test, p - 0.03; Figure 31). In contrast, subsequent to y-
irradiation a less than 10-fold increase in mutation frequency was detected with no
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Figure 30: Clonogenic survival of wild-type (E14, open symbols) and p53 null
(R72D5, solid symbols) cells following UVC-irradiation (A) and y-irradiation (B).
Data points represent the mean of two experiments for y-irradiation and three


















Figure 31: Hprt mutation frequencies of wild-type (E14, solid bars) and p53 null
(R72D5, open bars) cells subsequent to UVC-irradiation and y-irradiation. Each bar
represents a separate experiment.
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3.3.3 The Hprt mutation spectrum in p53-null ES cells following y-irradiation.
One potential source of error in the type of mutation assay used in this study is that
the mutation frequency may be overestimated due to the overgrowth of a small
proportion of clones. To address this issue and to obtain a more detailed picture of
the mutagenic events, the clonal origins of 22 6-TG resistant, yod-null colonies wrere
investigated. At the completion of the Hprt assay, colonies which had been exposed
to 7.6Gy y-radiation were analysed by PCR and Southern blotting.
Two PCRs were performed on cDNA samples from each clone, the first amplifying
the entire coding sequence of the Hprt gene and the second a control reaction
amplifying a 1265 bp region of the constitutively expressed Tbpl gene. Of the 22
clones analysed, all produced Tbpl PCR products whilst only eight produced Hprt
products (Table 4 and Figure 32). When the Hprt PCR products of these colonies
were sequenced, all eight were found to have distinctive mutations. These included
six deletions, ranging in size from three to 290 bp, one transition and one
transversion (Table 4). One of the clones (HI 2) produced two PCR products, the
first with a deletion of exons two and three and the other with only exon three
deleted, suggesting a mutation affecting the splicing machinery of the gene.
Where possible, clones were also analysed by southern blotting and hybridisation to
an Hprt cDNA probe. Restriction digest of the Hprt gene with the enzyme EcoRI
results in five fragments varying in size from 1.3 to 9.3kb (Thompson et al., 1989;
Figure 33A). An additional band, running between the 5.0 and 1.3kb bands, is often
seen and is derived from the pseudogene. Of those clones which had been
sequenced, all gave EcoRI restriction digest patterns which were consistent with their
known cDNA mutations (Tables 4 and 5, Figure 33). Of the remaining 12 clones
analysed, nine showed no labelled bands at all indicating deletion of the entire Hprt
gene, one had a deletion removing one of the primer sequences and two had lost
none of the expected bands suggesting either small changes in the PCR primer region
or loss of upstream control sequences (Table 5, Figure 33). The spectrum of
mutations observed were thus consistent with the type of mutations expected
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Figure 32: Typical examples of PCR (A) and sequencing (B) analyses ofmutant
Hprt clones. A: Upper panel, HPRT PCR reactions; lower panel, TPB1 PCR
reactions. M, OX 174 molecular weight marker (sizes of the upper four bands are
1.4, 1.1, 0.9 and 0.6kb); 1, E14 control reaction; 2, H23; 3, H21; 4, H31; 5, H27;
6, H28; 7, H11; 8, H10; 9, HH12; 10,H30; 11, H17; 12,H29; 13, H34. B:
Sequence ofwild-type (1) and mutant (2) Hprt PCR products. The arrow marks
the beginning of the deletion in clone H23.
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Figure 33: A: Structure of the wild-type Hprt gene (reproduced
from Thompson et al., 1989). Closed boxes, endogenous exons;
thick lines, endogenous introns; thin horizontal lines, flanking
sequence; cross-hatched boxes, promoter regions; thin vertical lines,
EcoRI sites. The number of each exon is shown above it and the size
(kb) of EcoRI fragments shown below and between sites. FP shows
position of forward primer and RP reverse primer. B: Typical
example of a Southern analysis of Hprt mutant clones. Clones were
digested with the restriction enzyme EcoRI and hybridised to an
Hprt cDNA probe. Sizes of expected restriction fragments are given
(in kb) to the left of the panel. Lane 1, HI 6; 2, HI 7; 3, HI 8; 4, HI 9;
5, wild-type pattern; 6, H23; 7, H24; 8, H26.
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Table 4: Mutations detected in the cDNA of the Hprt gene of eight Hprt deficient
ES cell clones. Positions ofmutations are given according to Konecki et al. (1982).
Clone Mutation Position Effect
H10 3 bp deletion 165 to 167 bp Deletion of one amino acid
(His)
H12 182 and 290 bp
deletion
224 to 406 and
116 to 406 bp
Exon 3 deleted
Exon 2 and 3 deleted
H19 47 bp deletion 573 to 619 bp Frameshift at 573 bp and stop
at 632 bp
H21 C to G 455 bp Stop at 455 bp
H23 290 bp
deletion
116 to 406 bp Exon 2 and 3 deleted
H26 246 bp
deletion
449 to 695 bp Deletion of part of exon 3 and
exons 4 to 8
H28 G to T 604 bp Stop at 604 bp
H29 39 bp deletion 60 to 99 bp Frameshift at 99 bp and stop at
115 bp
Table 5: Summary of EcoRI band patterns observed in Hprt mutants when
hybridised to Hprt cDNA. Sizes of the expected wild-type bands are given at the
head of each column. + indicates presence of the band, - indicates absence and R the
presence of a band reduced in size.
Clone 9.3kb 6.3kb 5.5kb S.Okb 1.3kb
H10 + + + + +
HI 1 + + + + +
H14 - - - - -
H16 - - - - -
H17 - - - - -
H18 - - - - -
H19 R + + + +
H20 - - - - -
H21 + + + + +
H23 + + - + -
H24 + - - + -
H26 - + + R +
H27 + + + + +
H28 + + + + +
H30 - - - - -
H31 - - - - -
H33 - - - - -
H34 - - - - -
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subsequent to this type ofDNA damage (reviewed by Sankaranarayanan, 1991).
Although it was not possible to examine the clonal origins of all Hprt mutants, the
lack of sibling colonies suggests that this was not a likely source of error in the Hprt
mutation assays.
Summary.
After both UVC and y-irradiation, clonogenic survival was reduced in a dose-
dependent manner but was consistently higher in yOi-null cells. Following UVC-
irradiation, a large dose-dependent increase in mutation frequency was observed but
surprisingly, the frequency inyoi-null cells was only two-fold higher than that in
wild-type cells. In contrast, subsequent to y-irradiation, a much smaller increase in
mutation frequency was detected with no significant difference between wild-type
and p53-null cells. Analysis of the mutagenic events leading to loss ofHPRT






The aims of this study were twofold. First to examine the effects of a j-null
environment on the induction of apoptosis in response to DNA-damage and to see
how this translated to survival in the longer term. Second, to determine the role of
p53 in the acquisition ofmutations, both with and without prior treatment with DNA-
damaging agents.
4.2 Methodological considerations.
One of the basic questions raised at the outset of this thesis was the nature of cells
that escape apoptosis as a result of defects in the pathway coupling DNA damage to
death. The techniques used in this thesis are able to accurately assess immediate
death, in terms of apoptosis, and ultimate clonogenic survival. However, to draw
quantitative conclusions linking numbers of cells that escape apoptosis to ultimate
survivorship requires knowledge not only of levels of apoptosis but also of cellular
proliferation and cell cycle arrest and how these vary over the time course of the
clonogenic assay. Whilst it is possible to accurately measure these parameters at a
single time point, an assessment over such a long time period is difficult.
Survival of cells at low density is known to be considerably poorer than at high
density and thus survivorship in clonogenic assays, where cell density is low, might
appear different from the survivorship of bulk cultures where cell density is higher
(Freshney, 1983). Consequently, a quantitative assessment of the absolute number of
mutant cells surviving DNA damage is difficult as this requires knowledge of both
the mutation frequency, which was assessed in bulk cultures, and clonogenic
survival.
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Variations in cell density may also account for the observed disparity in the levels of
apoptosis induced in otherwise identical experiments after both UVC and particularly
y-irradiation. This possibility was investigated in a series of experiments comparing
levels of confluence at the time of irradiation with the induction of apoptosis. Data
obtained from these experiments did suggest that cells irradiated at either very low or
high levels of confluence might be more resistant to the induction of apoptosis.
However, some variation was still observed between experiments even when cell
density was controlled for, indicating other causative factors. Such a relationship
might be explained in terms of the levels of cytokines and other metabolites to be
found in the tissue culture medium at differing levels of confluence. Whilst tissue
culture medium supplies a variety of growth factors, and in this case was
supplemented with LIF, ES cells also produce their own growth and differentiation
factors (Heath et ah, 1990). There is little data available on the effects of these
cytokines on ES cell survival and proliferation at low cell density but the reduced
proliferation of low density cultures suggests that these cytokines might be more
relevant to ES cell survival and proliferation than those supplied artificially. In
addition other metabolites that are able to pass through the cell membrane, for
example low molecular weight intermediary metabolites, would also be present only
at low levels in sparse cultures resulting in a steeper diffusion gradient than in dense
cultures. Thus at very low confluence levels, due to the scarcity of cells, levels of
relevant cytokines and intermediary metabolites would be low whilst at high
confluence levels they would be elevated. This might be expected to affect the
cellular sensitivity to apoptosis in several ways. First, in sparse cultures cellular
proliferation might be expected to be reduced and there is evidence to suggest that
some cell types are less susceptible to apoptosis when not actively cycling (Allan et
al., 1992; Evan et al., 1992; Ling et ah, 1995; Olive et ah, 1996). Second, depletion
of nutrients at higher confluence levels could also result in a reduction in the
proportion of proliferating cells and a consequent increase in the observed resistance
to apoptosis. In support of this theory, a study correlating cell cycle position with
confluence levels in these same cells has indicated that the proportion of cells in S-
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phase is lower in densely populated cultures (D. Connaughton. personal
communication). Finally, a number of studies have indicated that a variety of growth
factors can also act as survival factors and thus, at higher cell densities where levels
of relevant cytokines might be elevated, apoptosis might be reduced (Collins et al..
1992; Johnson et al., 1993; Yonish-Rouach et al., 1993; Gottlieb et al., 1994:
Canman et al., 1995). The experiments described in this study only assayed the
effects of confluence on apoptosis at a single time point and thus cannot exclude the
possibility that the observed variations are the result of alterations in the kinetics of
the induction of apoptosis rather than changes in sensitivity. However, clonogenic
survival in ES cells has been found to be correlated with confluence levels at the time
of UVC-irradiation (D. Connaughton, personal communication) and in other cell
types, has been shown to vary through the cell cycle (Hall, 1994).
Whilst confluence levels at the time of irradiation may account for some of the
variation in levels of apoptosis between experiments, there are clearly other causative
factors involved. The exact nature of these factors remains unclear. Cells were
derived from the same bulk freezes, experiments were set up in an identical manner
and, as far as it was possible to determine, culture conditions identical between
experiments. In most instances, culture medium constituents from the same batch
were used in consecutive experiments and where this was not possible, components
were batch tested before use. One possible source of variation that has not been
eliminated is that batches of components were tested under normal culture conditions
and the possibility remains that batches that sustain ES cell growth under these
conditions may differ in their performance when cultures are placed under high
stress. However, batches of components were large and consequently rarely changed
suggesting that differences in the culture medium are not likely to have been the
source of the observed variation between experiments.
Quantitative survival measurements require accurate dosimetry and whilst dosimetry
is well established for y-irradiation, no equivalent data was available for the UV
spectrolinker. In addressing this issue, it became clear that although this apparatus is
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frequently used in biological studies of the type presented here (Lu and Lane, 1993;
Prost et al., 1998) there are several problems associated with its use which required
both recalibration of the apparatus and changes in experimental design. Even if the
sensor, which was found to be faulty, were to be fully operational, the machine is not
capable of accurately delivering doses in the range commonly used in these types of
experiments. In addition, the lack of uniformity in light intensity in the irradiation
chamber, and shadow effect of cell culture vessels would be likely to further reduce
the dose accuracy. In many experiments where doses are not compared these errors
would not significantly affect the overall conclusions drawn from the data but they
would affect comparisons between data sets. The data clearly indicate the need to
calibrate and test all UVC-irradiation equipment prior to use, even if new as was the
apparatus used here.
4.3 The immediate response to DNA damage.
4.3.1 p53 and the apoptotic response to DNA-damaging agents.
In agreement with previous reports on both ES cells and other cell types, the data
show that there is a rapid induction and nuclear localisation of p53 protein in wild
type ES cells following exposure to UVC light (Maltzman and Czyzyk, 1984; Prost
et al., 1998) and that this induction appears to be associated with the initiation of
apoptosis (Lu and Lane, 1993). A similar rapid induction of apoptosis was seen
subsequent to treatment with the topoisomerase inhibitors, camptothecin and
etoposide and has previously been observed in embryonic carcinoma (EC) cells, a
cell type closely related to ES cells (Lutzker and Levine, 1996). As has formerly
been shown in both ES cells and other cell types, the apoptotic response to UVC-
irradiation was found to be reduced in /?53-null cells and showed an intermediate
response in heterozygote cell lines (Ziegler et al., 1994; Sabapathy et al., 1997). The
p53-dependence of the response to etoposide was more complex, with significant
levels of apoptosis being seen in /?5J-null cells only at higher doses. A similar partial
dependence of the induction of apoptosis on p53 has previously been seen in
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thymocytes following etoposide treatment (Clarke et al., 1993). A statistically
significant component of the /?55-null cultures entered apoptosis indicating the
presence of p53-independent apoptosis. Other studies on the effects ofUVC-
irradiation on yod-null ES cells have shown these cells do undergo apoptosis in
response to this type of damage but that it is delayed relative to the kinetics ofwild-
type cells (D. Connaughton, personal communication). In addition. Aladjem et al.
(1998) have shown that the apoptotic response to adriamycin in ES cells is p53-
independent. Thus, taken together with published data, the studies presented here
indicate that ES cells respond to DNA damaging agents with the induction of
apoptosis by routes only partially p53-dependent. The general importance of this
damage associated, p53-independent pathway is indicated by the fact that it has been
observed in many other cell types (Strasser et al., 1994; Malcomson et al., 1995; Li et
al., 1996; Aladjem et al., 1998).
In contrast, the response to y-irradiation was very different with little induction of
apoptosis observed subsequent to this type ofDNA damage. However, two distinct
phases of p53 expression were detected. The function of the immediate p53 response
to y-irradiation is uncertain as mock-irradiated cells showed a similar induction
suggesting that the response might be stress related. Mock UVC-irradiated controls
also showed a transitory elevation in p53 expression. Induction of p53 in response to
various stress stimuli, including hypoxia and heat-shock, has been reported by other
authors (Sugano et al., 1995; Renzing and Lane, 1995; Graeber et al., 1994) and thus
seems a likely explanation in this instance. This explanation concurs with the fact
that the exposure of the cells to y-irradiation, which involved substantially more
disruptions of culture conditions than did UVC-irradiation, resulted in a higher
proportion of positive staining cells among the handling-controls. A number of other
studies have shown a rapid and transitory induction of p53 subsequent to ionising-
radiation (Lu and Lane, 1993) but if this p53 response does occur in ES cells it would
clearly be masked by the observed stress response and thus its presence can neither
be confirmed or eliminated. A second, delayed phase of p53 induction, which
peaked 24 hours subsequent to y-irradiation, was observed in the
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immunocytochemical analysis but was not detected in the Western analysis. The
immunocytochemical method used here measures the proportion of cells showing
upregulation of p53 expression, irrespective of the degree of induction, whereas
Western analysis gives an estimate of the average cellular level of p53 protein and
thus, these two methods measure different parameters. An explanation compatible
with these differences would be that levels of induction, although widespread, are
low. Alternatively, this second peak of expression might be associated with the
initiation of apoptosis and differences between the two analyses could be attributed to
the observed variability in the induction of apoptosis after this type of DNA-damage.
A similar small increase in p53 expression was observed 18 hours after y-irradiation
by Aladjem et al. (1998) in another study on ES cells and confirms the importance of
this finding. In addition, a biphasic apoptotic response to ionising radiation has been
observed in both ES (Clutton et al., 1996) and EC cells (Langley et al,, 1994), the
timing of which closely follows the expression pattern of p53 seen here. It is
possible that the induction of p53 detected here is associated with the induction of
apoptosis but that the levels of apoptosis induced were outside the detection range of
the assays used in this study. The absence of an immediate apoptotic response in ES
cells is consistent with this cell type being highly resistant to ionising radiation but
does not necessarily imply that these cells would respond to higher doses of radiation
in the same manner. Studies on other cell types have shown that those that are
resistant to radiation, in terms of apoptosis, will often display delayed apoptotic death
at low doses but undergo a rapid wave of apoptosis at higher doses (reviewed by
Held, 1997).
The absence of an immediate wave of apoptosis following y-irradiation is surprising
considering the kinetics ofDNA damage anticipated, y-irradiation damages DNA
directly with single strand breaks (ssb), base and sugar damage and a smaller number
of double strand breaks being effected within milliseconds of the ionisation events.
The most commonly formed lesions subsequent to UVC exposure however, are
cyclobutane pyrimidine dimers and 6-4 photoproducts, which might not be expected
to immediately signal stabilisation of p53 and thence apoptosis, and which are
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converted to ssbs in a second set of reactions during NER in the damaged ceils.
Direct measurements of the kinetics of repair subsequent to y-irradiation are not
available for ES cells, but studies in other cell types suggest that the majority of
lesions are repaired rapidly, usually well within four hours (see Powell and
McMillan, 1990). In both ES and EC cells the majority of lesions caused by UVC-
irradiation are repaired within 24 hours but repair is not complete until 48 hours after
irradiation (Rasko et al., 1993; Prost et al., 1998). Similarly, although etoposide and
camptothecin induce strand breaks, repair of these lesions is delayed as the cleavable
complex formed by the binding of the topoisomerase inhibitors to topoisomerases is
bound to the DNA and thus blocks repair. The apparently contradictory nature of
these observations highlights certain questions. First, what is the trigger for p53-
dependent apoptosis in UVC damaged cells? Second, what is the trigger in the
absence of p53 and is it as efficient? Last, why do ES cells fail to enter apoptosis
subsequent to y-irradiation?
4.3.3 Cell cycle checkpoints in embryonic stem cells.
In agreement with previous reports on ES cells, a G2/M arrest was observed
following ionising radiation (Clutton et al., 1996). The arrest occurred in both wild-
type and p53-null cells and was maximal six hours after irradiation, persisting for
more than 24 hours. In their study on ES cells, Aladjem et al. (1998) were unable to
detect this arrest 18 hours after y-irradiation although, in the data presented here,
even 24 hours after irradiation, a highly significant increase in the proportion of
G2/M cells was observed in irradiated cultures. The reason for this discrepancy is not
clear, although Aladjem et al. do state that "no reproducible" Gi or G2/M arrest was
seen, suggesting that they may have observed an arrest in at least one experiment.
An S phase arrest has been observed in ES cells following UVC-irradiation, but this
was also p53-independent (Prost et al., 1998). In fact, despite several studies on the
effects ofDNA-damaging agents on wild-type and/Oi-null ES cells, there are no
reports in the literature demonstrating p53-dependent cell cycle checkpoints and it
has been suggested that this p53-dependent response to DNA-damage is absent in
this cell type (Aladjem et al., 1998). Relative to other cell types, undifferentiated ES
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and EC cells express high levels of p53 protein in the absence of injury and yet are
able to proliferate rapidly (Rogel et al., 1985; Li et al., 1996; MacCallum et al.,
1996; Sabapathy et al., 1997). Several authors have suggested that this is possible
because p53 is functionally inactive, at least in terms of transcriptional activation, in
these cells (Lutzker and Levine, 1996; Aladjem et al., 1998), but evidence for this is
contradictory (Sabapathy et al., 1997). However, induction of p53-dependent
apoptosis in EC cells by etoposide did result in upregulation of p53 and
transcriptional activation of p53 targets (Lutzker and Levine, 1996). Taken together,
these results suggest that ES cells are able to tolerate high, basal levels of wild-type
p53 and that it is only when p53 is upregulated in response to DNA damage that
induction of either cell cycle arrest or apoptosis follows. In the differentiated
derivatives of ES cells these high levels of expression are reduced and a proportion
of the p53 protein undergoes a conformational change to the form inactive for
transcriptional transactivation (Rogel et al., 1985; Sabapathy et al., 1997). In
addition, differentiation of ES cells restores the cell cycle arrest response to n-
phosphonacetyl-L-aspartate (PALA) treatment (Aladjem et al., 1998).
4.4 p53 and cell survival.
Clonogenic survival was also influenced by p53 genotype. After both y- and UVC-
irradiation the survival of/?J5-null cells, compared to wild-type, was enhanced in a
dose dependent manner. As predicted, a log linear response was observed following
both UVC- and y-irradiation, at least down to the level of 1% survival. In a previous
study examining clonogenic survival in ES cells after X-irradiation, Clutton et al.
(1996) found similar levels of survival to those observed in this study after low doses
of radiation (3.5 Gy and less) but significantly lower survival after high doses (10
Gy). The reason for this discrepancy is not entirely clear as the cell lines used were
closely related to those used in this study. The clonogenic assay used by Clutton et
al. was substantially different from the one used in this study, the main differences
being that trypsinised cells were passed through a 23 gauge needle to remove cell
clumps before being irradiated in suspension and that cells were cultured in medium
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supplemented with low melting point agarose. One possible explanation for the
observed differences in survival in the two studies might be that Clutton et al.
irradiated their cells in suspension, rather than as monolayers in flasks, which might
have adversely affected cell survival. However, Clutton et al. investigated this
possibility and found no differences in survival between the two irradiation protocols
(E. Wright, personal communication). Although the clonogenic assay used here did
show linearity over the range of plating densities examined it is not possible to
examine linearity at the higher densities required where high doses ofDNA-
damaging agents are used. Thus it is possible that the differences in clonogenic
survival observed in the two studies are the result of a breakdown in linearity at high
cell density.
The absence of a wave of apoptosis immediately after y-irradiation would be
consistent with the interpretation that either death is dependent on secondary DNA
breakage, perhaps effected during post-irradiation replication events or that the cells
do not die, but fail to proliferate. There is evidence in the literature for both of these
processes playing an important role in the response to ionising radiation. It has long
been known that lethally irradiated cells may undergo several cell divisions before
they lose their proliferative capacity (Thompson and Suit, 1969) and Seymour et al.
(1986) observed significantly decreased cloning efficiency as late as 30 cell divisions
post-irradiation. Similar results have been obtained with ES cells subsequent to X-
irradiation and a-particles (Clutton et al., 1996). In a later series of experiments,
Seymour and Mothersill (1992) found that this reduction in cloning efficiency was
the result of the production of sterile cells, many ofwhich are abnormal in
appearance and which fail to form viable colonies on replating. Studies on cell cycle
progression ofGo-Gi synchronised wild-type and yOJ-null fibroblasts after y-
irradiation have shown that, of those cells which escape the initial Go-Gi phase, many
undergo a permanent arrest in subsequent phases but that the proportion of cells
arresting is substantially lower inyoi-null cells than in wild-type cells (Linke et al.,
1997). In addition, it has been demonstrated that apoptosis can occur in irradiated
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cells post-mitotically (Radford and Murphy, 1994; Tauchi et ah, 1994; Yanagihara et
ah, 1995; Vidair et ah, 1996)
These results clearly demonstrate that clonogenic survival is increased in p53-null
cells but do not permit conclusions on the basis of this effect. It is tempting to
conclude, from the UVC data, that it relates to early apoptosis but the y survival data
do not reveal sufficient information on the p53-dependence of late death, if indeed
the reduction in survivorship is the result of death, for any conclusions to be drawn.
However, it is clear that the magnitude of the immediate apoptotic response is a very
poor indicator of the ultimate clonogenic survival, at least in response to y-
irradiation.
4.5 p53 and the mutation frequency.
The majority of studies to date investigating the effect of p53 on the spontaneous
mutation frequency of normal, murine cells have indicated that pdi-null cells do not
bear an increased mutation load (Nishino et ah, 1995; Sands et ah, 1995; Clarke et
ah, 1997) and the data obtained in this study on the spontaneous mutation frequency
of the Hprt gene is in agreement with these reports. These findings are further
supported by interbreeding experiments between Ape mutated (Min) and y?JJ-null
mice which show no evidence for an increase in the spontaneous rate of adenoma
formation in Ape +/-,p53 -/- mice compared with Ape +/-,p53 +/+ animals. As
adenoma formation is associated with the loss of the remaining wild-type Ape allele,
this suggests that the absence of p53 does not increase the spontaneous mutation
frequency in these mice (Clarke et ah, 1995). However, p53 status clearly does
influence spontaneous tumorigenesis in many other cell types, as demonstrated by the
phenotype of the /Oi-null mice (Donehower et ah, 1992; Jacks et ah, 1994; Purdie et
ah, 1994) and by several differentp53 intercrosses (Donehower et ah, 1995; Clarke
et al., 1995). It might be hypothesised from these results that the effects of a /?5J-null
background on genomic instability and the acquisition ofmutations at spontaneous
levels ofDNA damage are dependent upon cell type but as it is not known to what
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level the tissues examined were subjected to naturally occurring carcinogens it is
difficult to draw conclusions.
It is implicit from the strong association between DNA damage and p53 induction
that changes in p53 status may have significant effects on the mutation frequency
only following exposure to DNA damage. Surprisingly, an analysis of mutation at the
Hprt locus in cells surviving either y- or UVC-irradiation showed that mutation
frequency within surviving clones is largely uninfluenced by p53 status. We did
observe a small (two fold) but statistically significant increase following UVC
irradiation. The simplest explanation for these results is that efficient NER has a
more stringent requirement for functional p53 than does repair of y-irradiation
induced lesions and, as previously discussed, there is evidence in support of this
hypothesis. This explanation is not, however, supported by experiments using p53-
null Big Blue embryonic fibroblasts treated with the UV mimetic 4-nitroquinoline 1-
oxide (4NQO), which show no increase in mutation frequency (Sands et al., 1995).
One explanation for this discrepancy would be that again, the requirement for p53
may vary between cell types. A potential source of error in the type of assay used in
this study is that one or several mutant clones might acquire a growth advantage
resulting in an overestimation of the mutation frequency. However, it seems unlikely
that the data presented here are affected by such errors as an analysis of the clonal
origins of eight irradiated, 6-TG resistant, y>53-null clones revealed no sibling
colonies and, although it was not possible to examine the clonal origins of all Hprt
mutants, estimates ofmutation frequency were consistent between duplicated
experiments. The assay used in this study measures the proportion of surviving cells
which bear mutations but does not take into account any increases in the number of
cells that survive. Thus, although loss of p53 does not result in an increased
mutation frequency following y-irradiation, the number ofmutants surviving
irradiation is greater as a consequence of the increased survival ofy?J3-null cells.
Similarly, subsequent to UVC-irradiation, survival ofmutant cells is increased in the
absence of p53 due to both the increased mutation frequency and increased survival.
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4.6 p53 and chromosomal instability.
Previous studies of embryonic fibroblasts derived from p53-null mice and many p53-
null tumour cell lines have shown these cells to have unstable karyotypes when
cultured in vitro (Livingstone et al., 1992; Tsukada et al1993; Meling et al., 1993;
Carder etal., 1993; Purdie et al., 1994; Donehower et al., 1995). Although the ES
cell lines examined did possess some chromosomal abnormalities, they showed no
tendency to acquire further abnormalities over a ten week period of culture. This is
in contrast to /?55-null embryonic fibroblasts which over a similar period of growth
have been shown to display an increasing tendency towards aneuploidy (Livingstone
etal., 1992; Harvey et al., 1993; Tsukada etal., 1993).
Trisomy of targeted chromosomes has not been observed in other doubly targeted cell
lines derived using the same method (Mortensen et al., 1992) but appeared here in
three out of four /oi-null cell lines, derived in two separate experiments and
representing at least three unrelated clones. Whilst other possibilities exist, the most
likely explanation is that chromosome 11 has an inherent tendency towards trisomy
and this would be accentuated by the high G418 selection. This hypothesis is
supported by our own observations and several reports of spontaneous occurrences of
trisomy 11 in both ES and EC cells (McBurney, 1976; McBurney and Rogers, 1982;
Robertson and Bradley, 1986; Crolla et al., 1990).
It is possible some of the results obtained here arise as a consequence of chromosome
11 trisomy. However, we have observed normal growth and differentiation in these
ES cells and hence consider that compared to the majority of/o3-null cell lines
examined, they represent a relatively karyotypically normal cell line.
4.7 Conclusions.
This study has established a limited role for p53 in determining mutation within
clones surviving UVC-irradiation. However, the results described here derive from a
direct comparison of mutation amongst clonogenic cells. To understand the true
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consequences of p53 deficiency, the p53 dependency of clonogenicity must also be
considered. Thus, following y-irradiation, although the proportion ofmutant clones is
unaffected by p53 status, there is a dose-dependent increase in the number ofHprt
mutant clones as a direct consequence of the increased clonogenicity ofpoJ-null
cells. Similarly, following UVC irradiation, there is an increase in the number of
mutant clones, both as a result of the increased mutation frequency and as a
consequence of increased clonogenicity. Results similar to those presented here have
been obtained from an analysis of clonogenic IL7-dependent pre-B cells, which has
shown that the number of clones mutant at the Hprt locus is p53 dependent at
relatively low doses ofy-irradiation (Griffiths et al., 1997). As with ES cells, this
p53-dependent difference largely arises as a consequence of increased clonality.
However, our data contrast with a parallel study (Clarke et al., 1997) which scored
the mutation frequency at the Dlbl locus in clonogenic intestinal cells following y-
irradiation. This study indicated a role for p53 in preventing mutation, but only at
high doses (6 Gy). One hypothesis which would explain such cell lineage
differences would be that cell types differ in their reliance upon p53-dependent and -
independent mechanisms and also in their relative use of these mechanisms. Hence,
cells which survive genotoxic insult may be regarded as the end product of a complex
equilibrium of processes, some ofwhich are dependent on and others independent of
p53, and that the relative importance of these processes varies between cell type and
in response to different forms ofDNA damage. Similarly, for a given cell type loss
of p53-dependent mechanisms may only be significant at specific levels of a given
type ofDNA damage. In support of this hypothesis, we are able to demonstrate the
existence of both p53-dependent and -independent pathways in ES cells. This
hypothesis might also explain the difference between the UVC experiments presented
here and those of Sands et al. (1995) and also between UVC and y-irradiation in this
study, as p53-dependent mechanisms may not have been limiting at the doses
examined in these experiments.
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4.8 Future research directions.
The precise nature of the relationship between apoptosis and clonogenicity has
received relatively little attention. Various studies have attempted to examine this
relationship by looking at the induction of apoptosis in genetically similar cell lines
that differ in their clonogenic sensitivity. In many cases, a correlation between these
two variables has been found (Story et al., 1994; Han et al., 1995; Russell et al.,
1995) but this has not always been the case (Radford, 1994; Radford and Murphy,
1994; Xia et al., 1995). An alternative approach to this question has been to assess
the effects on clonogenic survival of treatments that modify the apoptotic response,
for example calcium chelation, caffeine and oxygen levels. Again results have been
conflicting and it appears that the type of modifying agent used is important
(Bernhard et al., 1996; Hopcia et al., 1996; Voehringer et al., 1997). For example,
calcium chelating agents might alter only the relatively late stage DNA cleavage and
merely repress the apoptotic death of cells that are nonetheless committed to die.
Another question that remains to be answered satisfactorily is whether or not
apoptosis can account for all of the cell loss in clonogenicity. Where studies have
assessed apoptosis only in the short term, the answer seems to be no (Dewey et al.,
1995; Hopcia et al., 1996) but some studies have suggested that if adequate time is
allowed for the cells to undergo apoptosis then it can account for all cell deaths
(Olive et al., 1996). All of these studies highlight the importance of assaying not
only immediate apoptosis but also delayed apoptosis. With the techniques commonly
used today, this is not usually possible. Most assays measure apoptosis only at a
single time point or up to the time of the assay. Also, where apoptosis is delayed
cells may divide several times before dying. All of these problems could be
circumvented with the use of time lapse microscopy.
A number of studies, including an analysis of the p53-dependence of the apoptotic
response to UVC-irradiation in ES cells, have suggested that loss of p53 does not
abrogate the apoptotic response to DNA-damage but merely delays it (Radford, 1994;
Xia et al., 1995; D. Connaughton, personal communication). A comparison of the
early apoptotic response to UVC-irradiation and the resulting clonogenic survival
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curve in pii-null ES cells observed in this investigation clearly indicates the
existence of p53-independent pathways to either cell death or the loss of
proliferative potential. Whether this loss of clonogenic potential results from a
delayed. p53-independent wave of apoptosis could be addressed by the use of time
lapse microscopy. In addition, there are several unanswered questions about the
relationship between apoptosis and clonogenic survival that could also be addressed
in such a study. For example; what proportion of clonogenic death can be accounted
for by apoptosis (immediate or delayed) and what role does p53 play in this
apoptosis, what is the role of differentiation in clonogenic loss and to what extent
does the type ofDNA damaging agent used affect the relative importance of these
processes.
Another question that remains to be answered satisfactorily is whether the sensitivity
to DNA-damaging agents differs between quiescent and proliferating cells. The data
presented in this study on the effects of confluence on the induction of apoptosis
suggest that this may indeed be the case, but a more rigorous investigation is clearly
required. An analysis of apoptotic sensitivity utilising cell cycle stage as a predictor
might produce clearer results. In addition, a careful investigation of any changes in
the kinetics of the induction of apoptosis and the long term consequences for
clonogenic survival would also be required.
In the analyses of p53 induction following y-irradiation presented here, a biphasic
response was seen in the Western analyses. The second peak of p53 expression was
not observed in the immunocytochemical analyses but it is not clear whether this was
due to differences in the parameters that these two types of assays measure or
because this second phase of expression is associated with the induction of apoptosis,
a response that is itself variable after this type of DNA-damaging agent. Concurrent
analyses of the induction of both p53 and apoptosis would address this problem.
At a more general level, why is it that some cell types are more sensitive to the
induction of apoptosis following ionising radiation than others? Studies in most
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normal tissues have shown a rapid induction of apoptosis within a few hours of
irradiation in both haematopoietic and non-haematopoietic cells. In tumour derived
cells, results are less consistent and many cell lines show either an increased
resistance to apoptosis or a delay in its induction (reviewed by Held, 1997). The data
presented in this study show very little induction of apoptosis (following y-
irradiation) in ES cells: a cell type which is both normal and rapidly proliferating and
thus might be expected to be very sensitive to the induction of apoptosis. It is
possible that the observed variation in tumour cell lines is the result of the acquisition
of genetic lesions but this seems an unlikely explanation in ES cells. Thus, the data
suggest that ES cells are in some way different from most normal cell types and an
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Glasgow modification of Eagle's medium (Life Technologies) supplemented
with the following reagents.
1. Non-essential amino acids (Life Technologies): Glycine (0.1 mM), L-
alanine (0.1mM), L-aspartic acid (0.1mM), 1-asparagine (0.1mM), L-glutamic
acid (0.1mM), L-proline (0.2mM) and L-serine (0.2mM).
2. L-glutamine (2mM, Life Technologies).
3. Sodium pyruvate (ImM, Life Technologies).
4. Foetal calf serum (5%, Sigma).
5. Newborn calf serum (5%, Globepharm).
6. |3-mercaptoethanol (O.lmM, Sigma).
7. Recombinant leukaemia inhibitory factor (LIF)-supplemented medium (0.05
to 0.2%V/V, according to titration).
TVP (cell disaggregating solution):
0.025% (W/V) trypsin, ImM EDTA and 1% chick serum (Life Technologies)
in PBS. Sterilised by filtration (0.2p, Gelman Sciences) and stored at -20°C.
1% Gelatin stock:
Gelatin (swine skin, Sigma) was dissolved in DDW, autoclaved, allowed to
cool to room temperature, re-autoclaved and then stored at 4°C. This stock was
diluted 1:10 with sterile DDW before use.
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HAT selection medium:
CM5-5 medium was supplemented with 0.1mM hypoxanthine (Sigma), 20uM
thymidine (Sigma) and 0.8 pM aminopterin (Sigma).
6 amino-6-mercaptopurine selection medium:
CM5-5 was supplemented with lOpg/ml 6 amino-6-mercaptopurine (6-TG,
Sigma).
G418 selection medium:







0.1% V/V Igepal CA-630 (Sigma).
pH 7.6.
Solution B:
0.5mg/ml trypsin inhibitor (type 11-0, Sigma).
























5% skimmed milk (Marvel).
Prepared freshly each day.
Avidin FITC:
4p. g/ml Avidin FITC DCS (Vector) freshly prepared in blocking buffer.
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Biotinylated anti-avidin:
5pg/ml biotinylated anti-avidin (Vector) freshly prepared in blocking buffer.
Propidium iodide stock solution:
lmg/ml propidium iodide in DDW (dH?0).
DAPI stock solution:
50pg/ml DAPI (Sigma) in dPLO.
Vectormount:
lml Vectormount antifadent (Vector).
1 pi propidium iodide stock.
20pl DAPI stock.
p53 immunocytochemistry and immunohistochemistry reagents.
Lysis buffer:
150mM NaCl.
1% Nonidet P40 (Sigma).
0.5% sodium deoxycholate (Sigma).
0.1% SDS.
Monomer solution (Severn Biotech Ltd):
30% w/v acrylamide.
0.8% w/v bis acrylamide.








12.5 ml monomer solution.
7.5 ml running gel buffer.
0.3 ml 10% SDS.
9.6 ml DDW.
150 pi 10% ammonium persulphate.
10 pi TEMED.
4% Stacking gel:
0.88 ml monomer solution.
1.66 ml stacking gel buffer.
66 pi 10% SDS.
4.06 ml DDW.




























Normal swine serum (NSS):
Normal swine serum (SAPU) was denatured for one hour at 65°C and then


















































0.1% bovine serum albumin (Sigma).













6% acrylamide/bis-acrylamide solution (Severn Biotech).
7M urea (Sigma).
1 x glycerol tolerant buffer (USB).
Stored at 4°C, protected from light.





Alphabetical list of common reagents and their suppliers.
Agarose; Sigma





Dimethyl sulfoxide (DMSO); Sigma
DTT (dithiothreitol); Sigma































Example of a typical flow cytometry analysis showing the gating protocols.
1: 2: fi
Hist Region ID % Count MnX MnY
1 A A 98.9 12174 55.9 67.5
2 B B 78.6 9564 376.3 428.4
3: A B 4:
FL3 FL3
Hist Region ID % Count PkPosX HPCV
3 D Hypodiploid 9.3 890 51.0 3.12
3 C G1 39.9 3812 307.0 3.24
3 E G2/M 17.1 1640 575.0 0.42
3 F S phase 32.2 3084 436.0 0.16
164
